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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
A vast amount of literature exists on the effects of purported ergogenic aids 
(performance enhancing drugs and supplements). Historic examples of athletes attempting to 
maximize performance include Roman and Greek athletes being advised by physicians to eat 
raw meat to maintain their “animal competitiveness,” and marathon runners in the 1908 
Olympics allegedly consuming brandy to improve performance (McArdle, Katch, & Katch, 
2010). In a survey of 53 coaches and athletic trainers at a Division I university, 94% of 
athletes were provided nutritional supplements (Smith-Rockwell et al., 2001). 
Consumption of carbohydrates may delay the onset of fatigue and improve aerobic 
exercise performance (Coggan & Coyle, 1987; Coyle et al., 1986). Carbohydrate ingestion 
may be especially beneficial during prolonged exercise (> 2 h) due to maintenance of the 
carbohydrate oxidation rate (Coyle et al., 1986) and prevention of hypoglycemia (Ivy et al., 
1979). Carbohydrate ingestion may also improve performance in shorter, high-intensity 
exercise (< 1 h; Neufer et al., 1987; Jeukendrup, 2004). Whereas the underlying mechanism 
for the improvements in exercise performance during shorter exercise bouts in which 
glycogen depletion is unlikely has not been elucidated, there may be central or nonmetabolic 
factors involved.  
Previous research has demonstrated that mouth rinsing with a carbohydrate solution 
enhances performance (Carter et al., 2004; Pottier et al., 2008; Rollo et al., 2008; Chambers 
et al., 2009; Rollo et al., 2010). Although the mechanisms for the improvement in 
performance are not yet defined, it has been hypothesized that presentation of energy to the 
mouth may stimulate reward centers of the brain that increase motivational drive and 
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exercise performance. Chambers et al. (2009) showed that non-sweet carbohydrate 
(maltodextrin) and glucose in the mouth produced similar cortical activation at rest and both 
solutions improved exercise performance, suggesting that mouth rinsing with both sweet and 
non-sweet solutions may improve performance by activating brain centers responsible for 
motor output and drive. Unidentified oral receptors may exist that respond to the caloric 
property of carbohydrate, independent of carbohydrate sweetness properties. 
The cephalic phase of insulin release (CPIR) has been observed in animals and 
humans. The β-cells of the pancreas secrete insulin before an increase in plasma glucose. 
Oral cavity stimulation with sweet, non-caloric substances stimulates the CPIR without 
affecting plasma glucose concentrations. Oral cavity stimulation with non-sweet, caloric-
containing substances does not stimulate the CPIR or affect plasma glucose concentrations 
(Tonosaki et al., 2007). It has been hypothesized that mouth rinsing with sweet carbohydrates 
may stimulate insulin secretion during exercise, potentially improving exercise performance. 
Branched-chain amino acids (BCAA; leucine, isoleucine, and valine) 
supplementation may be beneficial. Blomstrand (2001) suggested that the benefits of BCAA 
use are likely to be greater during activities in which the central component of fatigue plays a 
considerable role, such as exercise in the heat or during a competitive race. Plasma 
tryptophan is the amino acid precursor in the synthesis of 5-hydroxytryptamine (5-HT; 
serotonin) in the brain, and is involved in the control of arousal, sleepiness, and mood 
(Young, 1986). Increased free-tryptophan concentrations lead to increased serotonin 
synthesis, which is associated with lethargy, fatigue, and decreased exercise performance 
(Davis et al., 2000). Branched-chain amino acids may limit central fatigue by competing with 
free-tryptophan for uptake into the brain via the same transport mechanism (Pardridge and 
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Oldendorf, 1975; Blomstrand et al., 1997). Branched-chain amino acids supplementation has 
been shown to decrease perceived exertion and increase endurance performance (Blomstrand 
et al., 1991, 1997) and reduce brain serotonin synthesis (Gomez-Merino et al., 2001; Smriga 
et al. 2006). Whereas research has shown that BCAA supplementation may attenuate 
exercise-induced fatigue, some studies fail to corroborate these findings (Wagenmakers, 
1992; Varnier et al., 1994; Strüder et al., 1998). 
This dissertation research will determine if mouth rinsing with BCAA enhances 
exercise performance. This research will assess the extent to which improvement in 
performance is due to carbohydrates per se, or the presentation of energy to the oral cavity. 
Additionally, it is not currently known what effects rinsing the mouth with carbohydrates and 
branched-chain amino acids have on the concentration of blood glucose and lactate during 
exercise, the steady-state metabolic response to exercise, and the pancreatic secretion of 
insulin during exercise. Another major aim of this dissertation research is to determine the 
effects of mouth rinsing with carbohydrate and BCAA during exercise on markers of central 
(neural-based) fatigue. Plasma prolactin has been shown to be a measure of central serotonin 
levels (Yatham and Steiner, 1993) and will be used as the blood marker of central fatigue in 
the study. Finally, the effects of rinsing the mouth with carbohydrates and branched-chain 
amino acids on the subjective exercise experience and performance responses to exercise will 
be examined in the dissertation research. 
Dissertation Organization 
This dissertation is organized into a General Introduction, Review of Literature, 
Manuscript, General Conclusions, and an Appendix containing an additional manuscript 
prepared for journal submission. The primary author for the manuscript is Zebblin M. 
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Sullivan, a Ph.D. student in the Kinesiology department at Iowa State University. Dr. 
Douglas S. King, Professor of Kinesiology at Iowa State University contributed to the 
experimental design, data analysis, and preparation of the manuscript.  
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CHAPTER 2. LITERATURE REVIEW 
Introduction 
Nutritional ergogenic aids can be classified into four categories: substances that 
promote anabolism and improve body composition, substances that provide quickly utilizable 
energy, substances that facilitate recovery from physical exhaustion, and substances that fill 
other important roles in the physiology of exercise (Williams, 1995). Leucine, isoleucine, and 
valine are named branched-chain amino acids (BCAA) because their respective side chains 
are similarly branched in structure, unlike the other protein amino acids that have linear side 
chains. The BCAA are three of the nine essential amino acids for humans and must therefore 
be consumed in the diet. Branched-chain amino acids account for about 35% of the essential 
amino acids in muscle proteins (Harper et al., 1984).  
Leucine has been investigated more intensely than isoleucine or valine mainly 
because its rate of oxidation is higher than the other two BCAA (Mero, 1999). Whereas the 
other essential amino acids are oxidized primarily in the liver, BCAA can be oxidized in 
skeletal muscle (Rennie, 1996). During exercise, BCAA contribute to energy metabolism by 
providing intermediates for the tri-carboxylic acid (TCA) cycle. Additionally, BCAA may be 
transaminated to their respective α-keto acids, which are used for gluconeogenesis during 
exercise. The efficacy of BCAA supplementation on exercise performance has been posited 
to depend on several factors including the mode of administration (Verger et al., 1994), the 
nutritional status of recipients (Calders et al., 1997), use in conjunction with carbohydrates 
(Blomstrand, 2001), and the length and intensity of exercise (Strüder et al. 1998). Blomstrand 
(2001) argues that the benefits of BCAA use are likely to be greater during activities in 
8 
 
which the central component of fatigue plays a considerable role, such as exercise in the heat 
or during a competitive race. 
Branched-chain amino acids can be obtained from four sources: whole-food proteins, 
dietary protein supplements, solutions of protein hydrolysates, and free amino acids 
(Gleeson, 2005). There are four methods of consuming high amounts of BCAA – greater 
total energy intakes, deliberate consumption of high-protein diets and protein supplements, 
consumption of protein hydrolysates or mixtures of essential amino acids before and after 
exercise, and consumption of drinks containing BCAA (Gleeson, 2005). High levels of 
protein, amino acids, and/or BCAA may be consumed for one of several reasons. People 
wishing to increase muscle mass or lean tissue often consume high levels of dietary protein. 
Bodybuilders and weightlifters may consume up to 3 g/kg body mass of dietary protein 
(Jeukendrup & Gleeson, 2004). Infusion of BCAA, particularly leucine, has been shown to 
increase protein synthesis (Alvestrand et al., 1990) and decrease protein breakdown (Louard 
et al., 1990; Nair et al., 1992), potentially resulting in net protein accretion. Leucine 
stimulates the mammalian turnover of rapamycin (mTOR), a serine-threonine kinase 
involved in protein synthesis (Anthony et al., 2001; Kimball & Jefferson, 2006). 
Additionally, infusion of leucine into the third ventricle of the rat brain reduced voluntary 
food intake and body mass through activation of the mTOR pathway (Cota et al., 2006). 
Because prolonged exercise bouts increase BCAA uptake into muscle for oxidation for 
energy, endurance athletes may consumer higher amounts of dietary protein to meet the 
greater demands of BCAA oxidation. However, whereas there is a two- to three-fold increase 
in BCAA oxidation during exercise, the oxidation of carbohydrate and fat increases much 
more so, 10- to 20-fold during exercise (Wolfe et al., 1982; Knapik et al., 1991). 
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Furthermore, the activities of enzymes of BCAA oxidation are likely too low to allow a 
major contribution to energy expenditure from BCAA (Wagenmakers et al., 1989; 
Wagenmakers et al., 1991). Despite high intakes of protein being common among athletes, 
there is still much debate on the efficacy of higher protein intake on performance benefits. 
Branched-chain amino acids donate nitrogen for glutamine synthesis, helping to maintain 
plasma glutamine concentrations during exercise, which may enhance or strengthen the 
immune system. Some weak experimental evidence suggests that BCAA supplementation 
may attenuate immune system depression caused by prolonged strenuous exercise (Bassit et 
al., 2002). However, the strength and validity of the experimental design and statistical 
analysis of that study has been questioned (Calder, 2006). Further research is warranted in 
the area of BCAA supplementation and immune function.     
Catabolism of BCAA 
Branched-chain amino acids are essential for protein synthesis; however, some 
intermediates (branched-chain α-keto acids; BCKA) in their catabolism can be toxic at high 
concentrations (Harper et al., 1984). It is therefore imperative that excess BCAA are disposed 
of for maintenance of normal body function. The entire catabolism of BCAA occurs in the 
mitochondria. The first step in BCAA catabolism involves the reversible transamination of 
BCAA to produce BCKA, catalyzed by the enzyme branched-chain aminotransferase (Figure 
1). The next reaction in the catabolism of BCAA is the rate-limiting step of the pathway. This 
irreversible reaction, catalyzed by the enzyme branched-chain α-keto acid dehydrogenase 
(BCKDH) complex, involves the oxidative decarboxylation of BCKA to coenzyme A 
compounds. Because this is the rate-limiting reaction of BCAA catabolism, it is tightly 
regulated (Harris et al., 1990). The branched-chain α-keto acid dehydrogenase complex is 
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activated when dephosphorylated by BCKDH phosphatase and inactivated when 
phosphorlyated by BCKDH kinase. Apparently, BCKDH kinase is the primary regulator of 
the activation status of the BCKDH complex (Shimomura et al., 2001). The transamination 
of leucine forms α-ketoisocaproate (KIC), a potent inhibitor of BCKDH kinase (Paxton and 
Harris, 1984). Therefore, when KIC accumulates in tissues, the catabolism of branched-chain 
amino acids is stimulated. 
 
 
Catabolic pathway of branched-chain amino acids. 
 
 
 
Branched-chain amino acids 
(Valine, Isoleucine, Leucine) 
Branched-chain α-keto acids  
(α-ketoisovalerate, α-keto-β-methylvalerate, α-ketoisocaproate) 
α-Ketoglutarate 
Glutamate 
Branched-chain 
aminotransferase 
(BCAT) 
CoA-SH 
CO2 
NAD+ 
NADH + H+ 
Branched-chain α-keto 
acid dehydrogenase 
(BCKDH) complex 
(Active form) 
Branched-chain α-keto 
acid dehydrogenase 
(BCKDH) complex 
(Inactive form) 
ATP ADP Kinase 
Phosphatase 
Pi 
Acyl-CoA 
(Isobutyryl-CoA, α-methylbutyryl-CoA, Isovaleryl-CoA) 
Succinyl-CoA 
(TCA cycle) 
Acetyl-CoA 
Acetoacetate 
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 Endurance exercise stimulates energy expenditure including protein and amino acid 
oxidation. The BCAA pool is maintained by degradation of muscle proteins. However, 
during endurance exercise, the oxidation of BCAA may exceed the supply from proteins, 
decreasing the BCAA concentrations in the blood. Leucine oxidation increases with 
increased exercise intensity (Babij et al., 1983). Matsumoto et al. (2007) found that ingestion 
of a single dose of 2 g BCAA plus 0.5 g arginine resulted in a significant increase in plasma 
BCAA levels during three sets of 20-minute cycling at 50% maximal workload. They also 
found that the increase in plasma BCAA concentrations coincided with an increase in BCAA 
uptake into the muscle, whereas no increase in plasma BCAA levels or uptake of BCAA into 
the muscle was observed in the placebo trial. The group observed an exercise-induced 
increase in phenylalanine release from the leg during the placebo trial, indicating increased 
proteolysis. However, ingestion of 2 g BCAA suppressed phenylalanine (Phe) release, 
suggesting that supplementation of 2 g BCAA attenuates exercise-induced proteolysis.  
Exercise has been shown to activate the BCKDH complex. Using an electrically 
stimulated rat muscle contraction model, Shimomura et al. (1993) reported that increases in 
muscle leucine and KIC concentrations stimulate the BCKDH complex. Furthermore, the 
group also demonstrated that exercise decreases the amount of kinase bound to the BCKDH 
complex (Xu et al., 2001). The result of the aforementioned findings is an increase in BCAA 
catabolism during exercise. Additionally, endurance exercise training of rats decreases the 
amount of BCKDH kinase in their muscles, resulting in greater activation of the BCKDH 
complex (Fujii et al., 1998). The BCKDH complex of rats fed a low-protein diet was 
inactivated by BCKDH kinase phosphorylation in an effort to conserve BCAA for protein 
synthesis (Harper et al., 1984; Harris et al. 1990). However, when female rats were fed a 
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protein-deficient diet and performed a running exercise, the activity of the BCKDH complex 
was increased, suggesting that BCAA catabolism is increased during exercise even when 
dietary BCAA are undersupplied (Kobayashi et al., 1999).  
Fatty acid oxidation may be linked to BCAA oxidation. Administration of clofibric 
acid, a hyperlipidemic drug that stimulates fatty acid oxidation also stimulates BCAA 
catabolism. Long-term treatment with clofibric acid causes muscle wasting in animals (Paul 
& Adibi, 1979, 1980). Long-term administration of clofibric acid decreases BCKDH kinase 
activity in rats (Paul et al., 1996), which stimulates BCAA catabolism. It has been theorized 
that clofibric acid exerts its long-term effects on BCKDH kinase by activation of peroxisome 
proliferator-activated receptor-α (PPARα). Starvation increases fatty acid oxidation and thus 
circulating concentrations of fatty acids. Because fatty acids are ligands for PPARα, BCKDH 
kinase expression may be down regulated by starvation (Kobayashi et al., 2002). 
Additionally, fatty acid oxidation is stimulated by exercise. Exercise-induced increases in 
circulating fatty acids may therefore be associated with activation of the BCKDH, 
stimulating the increase in BCAA catabolism during exercise.         
Central Fatigue Theory 
Two broad types of fatigue exist – central and peripheral. Central fatigue refers to 
fatigue originating in the central nervous system. Peripheral fatigue is fatigue caused by 
factors outside the central nervous system, primarily in the muscle. Causes of peripheral 
fatigue include depletion of phosphocreatine, depletion of glycogen, accumulation of lactate, 
and malfunction of the neuromuscular transmission (Åstrand and Rodahl, 1986). The causes 
of central fatigue are less well known and are thought to involve primarily low blood glucose 
and changes in the plasma concentration of amino acids. Gandevia (2001) describes central 
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fatigue as the state in which modifications in the central nervous system diminish motor 
neuron impulse traffic to muscles. More precisely, Gandevia (2001) defines central fatigue as 
“a progressive reduction in voluntary activation of muscle during exercise.”   
Plasma tryptophan (Trp) is the amino acid precursor in the synthesis of 5-
hydroxytryptamine (5-HT) in the brain, which is involved in the control of arousal, 
sleepiness, and mood (Young, 1986). According to Fernström (1990), the rate-limiting step 
in the synthetic pathway of 5-HT is tryptophan crossing the blood-brain barrier. The 
concentration of free-tryptophan (not bound to the plasma carrier albumin) is thought to 
govern the rate of uptake in the brain. Tryptophan is the only amino acid that is bound to 
albumin in the plasma. Approximately 90% of the total tryptophan in plasma is bound to 
albumin; the remainder is in free form (Curzon et al., 1973). However, 5-50% of the total 
tryptophan pool can be in the free form (Fernstrom and Fernstrom, 2006). The concentration 
of free tryptophan in the plasma increases during, and particularly after, prolonged exercise 
bouts (Lehmann et al., 1995; Blomstrand et al., 1997). Animal exercise models have 
demonstrated that an increase in plasma free-tryptophan is linked to tryptophan 
concentrations in the brain whereas no such relationship between plasma total tryptophan and 
brain tryptophan was observed (Chaouloff et al., 1986; Blomstrand et al., 1989). Tryptophan 
crosses the blood-brain barrier via the L-system, the Large Neutral Amino Acid (LNAA) 
transporter (Blomstrand, 2001). Because BCAA are approximately 75% of the LNAA, and 
are transported via the same transport system (Fernstrom & Wurtman, 1972), they may 
compete with free tryptophan for uptake into brain. Increased free-tryptophan concentrations 
lead to increased serotonin (5HT) synthesis, which is associated with lethargy, fatigue, and 
decreased exercise performance (Davis et al., 2000). 
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Exercise has been shown to increase the activity of 5-HT in the brain in rats (Barchas 
and Freedman, 1963; Kirby et al., 1995). Administration of a 5-HT agonist during exercise 
decreases running performance in rats in a dose-response manner (Bailey et al., 1992), 
whereas administration of a 5-HT antagonist improves running performance (Bailey et al., 
1993). Wilson and Maughan (1992) found that administration of a 5-HT reuptake inhibitor 
decreased exercise performance when human subjects cycled until exhaustion at 70% VO2 
max. Increasing the ratio of free tryptophan to BCAA (fTrp:BCAA) increases the amount of 
free tryptophan that can cross the blood-brain barrier and is thought to increase the synthesis 
and release of 5-HT in the brain, causing central fatigue during and after prolonged exercise. 
Whereas direct measurement of brain 5-HT concentrations in humans may be inherently 
difficult, peripheral prolactin concentrations have been shown to be a surrogate index of 
brain 5-HT activity (Yatham and Steiner, 1993). 
The fTrp:BCAA significantly increases during and especially after prolonged 
exercise bouts. There are several events that occur during exercise that cause fTrp:BCAA to 
increase. The amount of BCAA that is taken up by the muscle increases, thereby decreasing 
the plasma concentration of BCAA and ultimately increasing the free tryptophan/BCAA 
ratio. Because albumin also binds and transports fatty acids in the plasma, the concentration 
of plasma free fatty acids may directly influence the plasma concentration of free-tryptophan 
(Knott & Curzon, 1972; Tagliamonte et al., 1971). During exercise, free fatty acids are 
released from adipose tissue causing albumin to release tryptophan and bind the fatty acids, 
thus increasing the amount of free-tryptophan (Curzon et al., 1973) and ultimately increasing 
fTrp:BCAA. The increase in fatty acid release from adipose during exercise is caused in part 
by the increase in circulating hormone levels, including epinephrine and norepinephrine 
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(Newsholme and Leech, 1983). Low levels of muscle glycogen may also influence the 
release of fatty acids from adipose tissue (Widrick et al., 1993), although the mechanism is 
not clearly understood.  
Branched-chain amino acids supplementation may decrease sensations of fatigue and 
lethargy, thereby improving exercise performance. This theory is known as the Central 
Fatigue Theory (Newsholme et al., 1987).The fTrp:BCAA in the plasma may be important 
for exercise-induced fatigue (Blomstrand, 2006). Exercise decreases plasma concentrations 
of leucine, isoleucine, and valine, while increasing free-tryptophan. BCAA supplementation 
may decrease the exercise-induced reduction of plasma BCAA, thus preventing an increase 
in fTrp:BCAA. Plasma BCAA concentrations increase in response to BCAA ingestion in a 
dose-dependent manner. However, plasma BCAA levels may return to baseline after one 
hour of ingestion of less than one gram BCAA. Plasma BCAA concentrations maintain 
elevated two hours after ingestion of more than 2 g BCAA (Hamada et al., 2005). Exercise 
intensity may influence fTrp:BCAA in plasma. Strüder et al. (1998), demonstrated that the 
changes in fTrp:BCAA during five hours of exercise depend on the intensity of exercise. 
They observed no changes in the ratio at 50% maximum oxygen uptake, but found that the 
ratio increased when participants exercised at 75% maximum oxygen uptake. 
Because fTrp:BCAA in the plasma is thought to influence fatigue, according to the 
Central Fatigue Theory, preventing an increase in the ratio may delay fatigue. Administration 
of BCAA before or during exercise causes a rapid increase in their plasma concentrations. 
Branched-chain amino acids are not taken up by the liver, thus countering the increase in free 
tryptophan and preventing an increase in fTrp:BCAA and theoretically delaying fatigue. 
Branched-chain amino acids may improve mood vigilance and limit central fatigue by 
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competing with free-tryptophan for uptake into the brain via the same transport mechanism 
(Blomstrand et al., 1997; Pardridge and Oldendorf, 1975). Branched-chain amino acids 
supplementation has been shown to decrease perceived exertion and increase endurance 
performance (Blomstrand et al., 1991, 1997) and reduce brain serotonin synthesis (Gomez-
Merino et al., 2001), consequently improving mental or physical performance or having no 
ergogenic effects (Davis et al., 1999). Blomstrand et al., (1997) examined the effects of 90 
mg/kg/body mass BCAA during exercise on mental fatigue and ratings of perceived exertion. 
Participants performed an exercise bout the night before testing to reduce glycogen stores, 
with the goal of increasing free tryptophan more quickly and subsequently causing fatigue 
more quickly. Participants performed cycle ergometer exercise for 60 minutes at 70% 
maximum oxygen uptake, followed by 20 minutes at their maximum. The ratings of 
perceived exertion and scores of mental fatigue were lower during the BCAA trial than the 
placebo trial (flavored water). Fourteen days of BCAA supplementation improved 40 km 
time-trial performance of competitive cyclists (Hefler et al., 1995). Performance in triathlons 
lasting three hours or longer was improved by increased fatty acid oxidation in response to 
14 days of BCAA supplementation (Kreider et al. 1991). 
Crowe et al. (2006) examined the effects of six weeks of leucine supplementation (45 
mg/kg body mass/day; ~ 3.3 g/day) in competitive outrigger canoeists. The study population 
was chosen because they commonly compete in both sprint and endurance events, providing 
an excellent population on which to study the effects of chronic leucine supplementation on 
endurance and power. The average training duration during the six weeks was 3.7 ± 0.3 and 
3.8 ± 0.2 hours per week outrigging training plus 4.5 ± 2.1 and 4.3 ± 1.6 hours per weeks 
cross training (resistance training, cycling, & jogging) for the leucine and placebo groups, 
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respectively. Six weeks of leucine supplementation increased row time to exhaustion at 70-
75% VO2 max (77.6 ± 6.3 to 88.3 ± 7.3 min; pre- to post-supplementation, respectively), 
whereas the placebo group showed no improvement. Average ratings of perceived exertion 
(RPE) of the leucine group was significantly lower during the row to exhaustion test after six 
weeks of supplementation (14.5 ± 1.5 to 12.9 ± 1.4; pre- to post-supplementation, 
respectively), suggesting a reduction in central fatigue, whereas the placebo group was 
unchanged. Relative peak power during a ten-second arm crank test increased after six weeks 
in both placebo and leucine groups. However, the increase in relative peak power after six 
weeks of leucine supplementation was significantly greater, compared to placebo (6.7 ± 0.7 
versus 6.0 ± 0.7 W kg-1, respectively). Row to exhaustion significantly decreased plasma 
leucine (145.1 ± 4.0 to 143.2 ± 4.0 µmol), isoleucine (76.8 ± 2.3 to 75.0 ± 2.2 µmol), valine 
(262.0 ± 4.6 to 250.0 ± 4.5µmol), and therefore, total BCAA concentrations (483.9 ± 10.4 to 
478.2 ± 10.3 µmol). The exercise resulted in an increase in plasma free tryptophan (13.4 ± 
0.8 to 14.0 ± 0.7µmol) and subsequently fTrp:BCAA (0.0280 ± 0.0020 to 0.0294 ± 0.0017 
µmol). Leucine supplementation did not affect fTrp:BCAA; there was no difference in 
fTrp:BCAA between the leucine and placebo groups pre- or post-supplementation before or 
after exercise. These findings suggest improvements in endurance performance and upper 
body power may be realized from leucine supplementation irrespective of changes in 
fTrp:BCAA in plasma. The authors posit that the improvement in exercise performance from 
leucine supplementation was not mediated by a reduction in central fatigue, as there was no 
reduction in the ratio of fTrp/BCAA. The authors suggest the improvement in row time to 
exhaustion and relative peak power output during the ten-second arm crank test from six 
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weeks of leucine supplementation may have been caused by reducing training-induced 
muscle damage and enhanced recovery from training, resulting in increased performance.  
Smriga et al. (2006) tested whether 5-HT release increases in areas of the brain 
involved in recognition of amino acids (hypothalamus) and emotional response to stress 
(amygdala) during exercise and if oral BCAA infusion moderates an exercise-induced 5-HT 
release. Rats were given a 55-min acclimatization period and were orally infused with either 
8 ml water or 8 ml BCAA-based solution. Rats then ran on treadmills for one hour at speeds 
of either 5 m/min or 25 m/min; running at higher speeds increased circulation corticosterone 
concentrations in both infusion groups. The BCAA solution increased plasma BCAA, 
lowered tryptophan, and lowered fTrp:BCAA. Running at 25 m/min increased neuronal 5-
HT release in the lateral hypothalamus in the water-infused group; however, BCAA infusion 
prevented such an increase. Serotonin release from the lateral hypothalamus 60 and 80 
minutes post-exercise was significantly greater in the water-infused group than the BCAA-
infused group. Treatment did not affect 5-HT release in the central nucleus of amygdala. 
According to the authors, serotonin terminals projecting to the lateral hypothalamus and 
amygdala are involved in the regulation of stress, food intake, and fatigue – all potentially 
influenced by BCAA because BCAA infusion significantly blunted exercise-induced 5-HT 
release. However, because BCAA infusion did not affect corticosterone concentrations, the 
stressfulness of running was probably unaffected. 
Some controversy exists on the efficacy of BCAA in regard to attenuating central 
fatigue. Whereas research has shown that BCAA supplementation may attenuate exercise-
induced fatigue, some studies fail to corroborate these findings (Strüder et al., 1998; 
Wagenmakers, 1992; Varnier et al., 1994). According to Fernstrom & Fernstrom (2006), the 
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general consensus is that binding of albumin to tryptophan does not influence brain uptake of 
tryptophan to any meaningful level. Madras et al. (1974) tested the effects of high fat diet 
consumption by rats on serum concentrations of non-esterified fatty acids (NEFA) and free 
tryptophan. The diets contained 20% protein and either 0, 15, 30, or 45% fat. They found that 
as fat consumption increased, serum NEFA and free tryptophan concentrations increased in a 
dose-dependent manner. However, the concentration of tryptophan in the brain was not 
altered, providing evidence against the regulatory action of free-tryptophan in the blood on 
brain tryptophan uptake and concentration. The major critique of this study was the inclusion 
of protein in the diet. The dietary protein should increase the level of LNAA in blood, which 
compete for transport with tryptophan across the blood-brain barrier, effectively blunting any 
potential increase in tryptophan uptake and ultimately brain tryptophan levels. Because 
protein ingestion raises blood LNAA concentrations and insulin secretion lowers LNAA 
concentrations, both of which may influence fTrp:BCAA, and subsequent tryptophan uptake 
into the brain, Fernstrom & Fernstrom (1993) conducted a well-controlled experiment to 
assess the influence of blood NEFA on brain tryptophan levels. They fed streptozotocin 
diabetic rats, which cannot secrete insulin, a carbohydrate meal containing 0 or 45% fat. The 
high fat diet significantly increased serum NEFA (0.56 ± 0.10 to 1.14 ± 0.11mEq/L) and 
produced a two-fold increase in free tryptophan concentrations, with no effect on total 
tryptophan levels two h after meal presentation. Furthermore, the ratio of free-
tryptophan:LNAA increased (0.030 ± 0.002 to 0.082 ± 0.011). However, despite the increase 
in serum free-tryptophan and the ratio of free-tryptophan:LNAA, the concentrations of 
tryptophan in the cortex and hypothalamus were unaffected. These findings question whether 
the level of brain tryptophan is dependent on the concentrations of free-tryptophan. 
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Chaouloff et al. (1985) examined whether the rise in brain tryptophan during exercise 
is dependent on an increase in NEFA. They found that running for two hours caused time-
dependent increases in plasma free tryptophan, NEFA, and consequently, brain tryptophan in 
rats, leading to greater rates of 5-HT turnover, as measured by its metabolite, 5-
hyroxyindolacetic (5-HIAA). Administration of valine to running rats completely prevented 
the exercise-induced increase in brain tryptophan and 5-HIAA. However, administration of 
nicotinic acid, an inhibitor of hormone-sensitive lipase, completely abolished the running-
induced increase in plasma NEFA and plasma free-tryptophan, yet still resulted in an 
increase in brain tryptophan. Chaouloff et al. (1987) suggested that increased dopamine 
concentrations in the brain may inhibit 5-HT synthesis during exercise, and therefore, 
attenuate fatigue. The amino acid precursor in the biosynthesis of dopamine is tyrosine (Tyr). 
Tyrosine may be synthesized from phenylalanine. However, because BCAA administration 
lowers the ratio of Tyr + Phe:BCAA, dopamine synthesis may be lessened when participants 
are given BCAA. Because dopamine may inhibit 5-HT synthesis, additional BCAA intake 
may theoretically lower the inhibition of serotonin synthesis, actually leading to fatigue. 
These findings suggest that increases in brain tryptophan can occur independently of changes 
in plasma NEFA and free tryptophan and BCAA supplementation may potentially dampen 
the inhibitory actions of dopamine on serotonin synthesis.  
Others have demonstrated that BCAA administration 70-90 minutes before short-term 
exercise does not affect physical performance (Wagenmakers, 1992; Varnier et al., 1994). 
Wagenmakers (1992) had participants exercise to exhaustion (about 30 minutes) in a partially 
glycogen-depleted state. Varnier et al. (1994) studied the effects of administering BCAA 
before a graded incremental exercise test to exhaustion, lasting approximately 40 minutes. 
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The amount of BCAA ingested during the studies by Wagenmakers et al. and Varnier et al. 
was 20-30 g total, an amount that may have negative effects on exercise performance due to 
a potential increase in ammonia from the muscles, causing an increase in blood levels of 
ammonia, which may cause fatigue. Strüder et al., (1998) examined the effects of 21 g of 
BCAA supplementation on exercise time to exhaustion. They found that BCAA 
supplementation did not affect time to exhaustion, heart rate, capillary lactate, plasma insulin, 
free fatty acids, glucose, serotonin, and beta-endorphin levels. Plasma ammonia increments 
were higher in the BCAA trial. Branched-chain amino acids supplementation did not 
attenuate the exercise-induced increase in prolactin, growth hormone, cortisol, ACTH, 
epinephrine, or norepinephrine. The ratio of tryptophan:BCAA did not increase in the BCAA 
trial, unlike the placebo, paroxetine, and tyrosine trials. Drive during psychometric testing 
subsequent to exercise was improved in the BCAA trial. Whereas fatigue during endurance 
exercise was increased by pharmacological augmentation of the brain serotonergic activity, a 
reduction in 5-HT synthesis via BCAA supplementation did not affect physical fatigue.  
Prolonged hyperthermia increases blood-brain barrier permeability and 5-HT 
accumulation (Sharma & Dey, 1987). Increased 5-HT accumulation may augment fatigue. 
Mittleman et al. (1998) examined the effects of BCAA supplementation (approximately 9 g, 
females; 16 g males) on performance of a cycle ergometer ride (40% VO2 max) to exhaustion 
in the heat (34°C). Exercise was performed in the heat to increase central fatigue. Mittleman 
et al. (1998) found that BCAA ingestion increased ride to exhaustion time from 137 to 153 
minutes, compared to placebo. However, Watson et al. (2004) observed no effect of BCAA 
supplementation before and during exercise on exercise to exhaustion at 50% VO2 max in a 
warm environment (30° C). Participants exercised in a glycogen-depleted state. Four 250 ml 
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aliquots of BCAA (12 g/l) were ingested in 30-minute intervals before exercise and 150 ml 
aliquots were consumed every 15 minutes during exercise. BCAA ingestion did not affect 
heart rate, core temperature, or weighted mean skin temperature during exercise. Whereas 
ingestion of BCAA did not affect exercise capacity in the heat, BCAA ingestion did lower 
fTrp:BCAA in plasma, compared to placebo. This finding refutes the Central Fatigue Theory. 
Treatment had no effect on blood glucose or lactate concentrations. Ingestion of BCAA did 
elevate plasma ammonia during exercise, whereas plasma ammonia concentrations did not 
change in the placebo group. The findings of Watson et al. (2004) suggest that exercise 
capacity in the heat is not hindered by greater ammonia concentrations and is not influenced 
by fTrp:BCAA in the plasma.  
If administration of BCAA decreases fTrp:BCAA and consequently attenuates central 
fatigue, one could hypothesize that administration of tryptophan would increase fTrp:BCAA 
and augment central fatigue. Farris et al. (1998) found that infusion of tryptophan to horses 
decreased running time to exhaustion at 50% VO2 max (87 vs. 122 minutes for tryptophan 
and saline infusion, respectively). Additionally, Weicker and Strüder (2001) found that 
endurance-trained male cyclists reached time to exhaustion during cycle ergometry 
significantly earlier when administered 20 mg paroxetine (selective serotonin reuptake 
inhibitor, SSRI; 131 ± 53 min) than placebo or 14 g BCAA (157 ± 53 and 152 ± 41 min, 
respectively). After the exercise bout, participants were given a cognitive test (KL-test, 
Düker 1976). Lower scores for subjects’ drive or motivation (95.1 ± 34.4 and 108.9 ± 43.3 
for SSRI and placebo, respectively) and a greater percentage of incorrect responses (4.8 ± 3.9 
and 7.8 ± 4.8 for SSRI and placebo, respectively) were observed in the paroxetine trial versus 
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the placebo trial. The authors suggest that the reduction in physical performance observed in 
the SSRI trial may have been caused by a reduction of 5-HT in the synaptic cleft.  
Carbohydrates, BCAA, and Central Fatigue  
Consumption of carbohydrates during prolonged exercise may improve performance 
by maintaining blood glucose levels and central nervous system function. Carbohydrate 
consumption may decrease central fatigue by attenuating the exercise-induced rise in plasma 
free fatty acids (Wright et al., 1991; Widrick et al., 1993; McConell et al., 1999), the 
subsequent displacement of tryptophan from albumin, and consequently plasma free 
tryptophan (Davis et al., 1992). Consumption of carbohydrate stimulates insulin secretion, 
which is known to inhibit lipolysis, and stimulate lipogenesis, thereby decreasing plasma free 
fatty acid levels. However, during exercise that lasts two to three hours, an increase in plasma 
free fatty acids is observed, despite consumption of carbohydrates (Wright et al., 1991; Davis 
et al., 1992; McConell et al., 1999). The increase in plasma free fatty acids is likely caused 
by low levels of glycogen, blood glucose or insulin. Because prolonged exercise lowers 
muscle glycogen levels and stimulates the uptake of BCAA into muscle for oxidation 
(Blomstrand and Newsholme 1992), fTrp:BCAA increases during exercise. Because 
fTrp:BCAA increases during exercise, the ratio of fTrp:LNAA (large neutral amino acids) 
also increases during exercise, leading to an increase in cerebral total tryptophan (free and 
bound) and brain 5-HT synthesis. According to Weicker and Strüder (2001), an over-
proportional release of tryptophan from albumin occurs and, as a result, higher levels of 5-
HT are synthesized in the brain during states of glycogen depletion. Nutritional interventions 
using carbohydrate and/or BCAA may therefore cause alterations in the manifestation of 
central fatigue during exercise.    
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Several studies have investigated the effects of BCAA plus carbohydrate intake on 
physical performance. Divergent findings exist on the additional benefit of BCAA 
supplementation over carbohydrate ingestion alone. Welsh et al. (2002) reported that 
carbohydrate ingestion increases physical and mental function during intermittent exercise. 
Most have observed no additional benefit of BCAA over carbohydrate ingestion alone 
(Blomstrand et al., 1995; van Hall et al., 1995; Madsen et al., 1996; Davis et al., 1999). 
However, Blomstrand et al. (1991) found that slower runners given BCAA improved 
performance in a marathon run. The results obtained by Davis et al., (1999) do not support 
the hypothesis of an added benefit of BCAA supplements on fatigue. They found that both 
carbohydrate one hour before (5 ml/kg; 18% carbohydrate) and during (2 ml/kg; 6% 
carbohydrate) intermittent exercise to fatigue (shuttle running; walking, sprinting, and 
running) and carbohydrate plus 7 g BCAA increased time to exhaustion compared to a 
flavored water placebo trial. The addition of BCAA did not yield any added physical 
performance benefit. Plasma insulin and glucose were higher and FFA were lower in the 
carbohydrate and carbohydrate plus BCAA trials than the placebo trial.  
Kaastra et al. (2006) tested the potential additive effects of protein and leucine 
ingestion with carbohydrates on insulin secretion and glucose disposal during recovery from 
exercise in endurance-trained males. They observed that ingestion of a protein hydrolysate 
with carbohydrates and ingestion of a protein hydrolysate, free leucine, and carbohydrates 
increased insulin secretion more than ingestion of carbohydrates alone (108 ± 17 and 190 ± 
33 % greater, respectively), but did not affect plasma glucose disposal. Cheuvront et al. 
(2004) examined whether BCAA supplementation affects performance when participants 
were hypohydrated by 4% body mass and were glycogen-depleted. They found that BCAA 
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when combined with carbohydrate does not provide any additive benefit on physical 
performance over carbohydrate ingestion alone under conditions in which central fatigue 
may have been exacerbated by alterations in serotonergic function. However, BCAA 
ingestion resulted in an increase in plasma BCAA, and a decrease in the ratios of total 
Trp:BCAA and total Trp:LNAA, compared to a carbohydrate placebo. Neither carbohydrate 
nor carbohydrate plus BCAA affected plasma FFA or prolactin concentrations. Interestingly, 
participants’ heart rates were higher during the BCAA plus carbohydrate trial than the 
carbohydrate placebo trial. No treatment effect was observed for ratings of perceived 
exertion, thermal comfort, mood as measured by the POMS, or any test of cognitive function 
(four-choice reaction time, visual vigilance, match-to-sample, repeated acquisition, and 
grammatical reasoning).  
Ingestion of carbohydrates may reduce the uptake of tryptophan into the brain. 
Blomstrand et al. (2005), observed that during prolonged exercise (three hours of cycle 
ergometry at 200 ± 7 Watts), carbohydrate ingestion (6%) attenuated the uptake of 
tryptophan into the brain, as measured by the difference of radial artery and jugular venous 
blood concentrations multiplied by plasma flow. In the placebo (flavored water) trial, 
approximately 106 µmol (22 mg) of tryptophan was taken up by the brain during exercise, 
which began 30 minutes into the three hour exercise bout and continued for the remaining 2.5 
hours. No uptake of tryptophan was observed in the carbohydrate trial. The arterial 
concentration of free tryptophan increased to a greater extent during the placebo trial, 
compared to the carbohydrate trial (12 ± 1 to 20 ± 2 µ mol L-1 during the placebo trial, 
compared to 14 ± 1 µ mol L-1 at the end of the carbohydrate trial). The concentration of total 
tryptophan (free and bound) increased during the first 30 minutes of both trials, but returned 
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to baseline at 180 minutes of exercise. Branched-chain amino acids were taken up by the 
brain in both trials. No correlation between plasma free tryptophan or fTrp:BCAA in blood 
and the uptake of tryptophan into the brain were found. However, in exercising animal model 
studies, a proportionate increase in plasma free tryptophan (not total) and increase in brain 
tryptophan has been observed (Chaouloff et al., 1986).  
BCAA and Anaerobic Performance 
The effects of BCAA supplementation on anaerobic exercise performance have not 
been extensively studied. Acute ingestion of leucine (200 mg/kg body mass) before a 
maximal anaerobic running exercise session until exhaustion had no effect on performance of 
the test, compared to placebo (Pitkänen et al., 2003). Serum leucine was higher in the leucine 
supplementation group than the placebo group both ten minutes before and ten minutes after 
exercise and was higher after the exercise session in response to leucine supplementation. 
Isoleucine and valine concentrations were lower after exercise than before in the leucine 
group. The group also tested the effects of acute ingestion of leucine (100 mg/kg body mass) 
before and during a strength exercise session. Leucine ingestion did not affect performance 
of a counter movement jump. The effect on leucine ingestion before and after a strength 
exercise session on serum amino acid concentrations was similar to that of the maximal 
anaerobic running session. Serum leucine concentrations were higher in the leucine 
supplemented group before and after exercise, compared to placebo. Serum leucine 
concentration decreased after exercise in the placebo group, whereas leucine supplementation 
prevented an exercise-induced decrease in serum leucine. Serum isoleucine and valine 
decreased more after exercise in the leucine group than the placebo group. The participants in 
this study were competitive male power athletes. It is possible that their performance on 
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anaerobic running tests or counter movement jump tests are already rather high, therefore 
acute ingestion of leucine is unlikely to provide an ergogenic benefit. Additionally, counter 
movement jumping is a high-skill power movement. Perhaps acute ingestion of leucine may 
improve power output in less skill-intense tests.  
Crowe et al. (2006) found that relative peak power during a ten-second arm crank test 
increased after six weeks of supplementation and cross training in both placebo and leucine 
treatment groups. However, the increase in relative peak power after six weeks of leucine 
supplementation was significantly greater compared to placebo (6.7 ± 0.7 versus 6.0 ± 0.7 W 
kg-1, respectively). Leucine supplementation did not influence total work performed in the 
ten-second arm crank test. Vukovich et al. (1992) found that seven days of supplementation 
with an amino acid mixture (0.8 g/kg body mass; rich in BCAA) did not affect power output 
during a Wingate test; however, a trend for lower percent fatigue was observed in the amino 
acids trial, compared to placebo (44.82 ± 2.21 and 51.45 ± 2.98% for amino acids and 
placebo, respectively). These findings question the efficacy of BCAA supplementation on 
anaerobic exercise performance. 
BCAA and Buffer Capacity 
Branched-chain amino supplementation may influence lactate accumulation in the 
blood during exercise. Lactate in the blood increases when the rate of lactate production 
exceeds the rate of lactate removal. Pyruvate is the end-product of glycolysis. The four fates 
of pyruvate are 1) enter the Kreb’s cycle as Acetyl CoA, 2) transaminated to alanine, 
catalyzed by the enzyme glutamate pyruvate transaminase (GPT), 3) transported to the liver 
for gluconeogenesis, and 4) reduced to lactate, catalyzed by the enzyme lactate 
dehydrogenase. Increased BCAA availability has been shown to increase the transamination 
28 
 
of pyruvate to alanine (Odessey et al., 1974), thereby decreasing lactate formation (Mole et 
al., 1973), potentially ameliorating the onset of fatigue. Vukovich et al. (1992) found that 
seven days of supplementation with an amino acid mixture (0.8 g/kg body mass; rich in 
BCAA) significantly lowered participants’ blood lactate concentrations when they exercised 
at intensities greater than 100% VO2 max, but did not affect blood lactate concentrations at 
intensities less than 100% VO2 max. They also found that concentrations of blood alanine 
were higher at all exercise intensities (40, 60, 80, 100, & 120% VO2 max). Whereas amino 
acid supplementation did not affect power output during a Wingate test, a trend for lower 
percent fatigue was observed in the amino acids trial. Muscle lactate and muscle glycogen 
concentrations were lower after the Wingate test in the amino acid trial than the control. 
Seven days of amino acid supplementation significantly increased pre-exercise GPT activity 
by 47%, but had no effect on the activity of citrate synthase (CS), a Kreb’s cycle enzyme.  
Maresh et al. (1991) observed lower blood lactate concentrations after a Wingate test 
when participants consumed an amino acid supplement. They posited the lower lactate 
accumulation was due to increased transamination of pyruvate, increased oxidation of amino 
acids, decreased lactate efflux from muscle to blood, reduced intracellular ammonia 
accumulation, or increased clearance of lactate by the liver. The findings of Vukovich et al. 
(1992) on increased GPT activity in response to amino acid supplementation support the 
theory of increased transamination. The authors suggest the increase in GPT activity after 
amino acid supplementation is likely due to increased amino acids available as substrate for 
GPT production, increasing the amount of the enzyme, which increase its activity. 
Furthermore, BCAA are the primary amino acids involved in the transamination of 2-
oxoglutarate to glutamate, the reaction immediately preceding that catalyzed by GPT. 
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Increasing the activity of GPT may increase the transamination of pyruvate to alanine, 
decreasing the reduction of pyruvate by lactate dehydrogenase to lactate, potentially 
decreasing the amount of lactate in the blood and muscle (Mole et al., 1973).  
Branched-chain amino acid supplementation may improve muscle buffering capacity. 
Because most athletes and the general population combine aerobic and anaerobic training, 
Vukovich et al. (1997), studied the effects of six weeks of BCAA plus glutamine and 
carnitine supplementation (2.9 g/day) on untrained people performing combined aerobic and 
anaerobic training. The authors also studied the effects of seven days of BCAA 
supplementation without exercise on muscle and blood lactate accumulation. They found that 
seven days of supplementation without exercise training did not affect peak oxygen 
consumption, power output associated with onset of blood lactate accumulation (4 mM; 
OBLA), and blood lactate concentrations. Time to ride to exhaustion at 120% VO2 peak, 
muscle lactate, pH, and buffer capacity after the ride to exhaustion were not affected by 
seven days of BCAA supplementation. Six weeks of combined aerobic and anaerobic 
training increased peak oxygen consumption, power output at OBLA, and ride time to 
exhaustion at 120% VO2 max. There was no additional benefit from BCAA supplementation. 
Blood lactate concentration at VO2 peak was not affected by training or supplementation. In 
vivo buffer capacity increased significantly after two weeks of training in the BCAA group; 
this increase was not observed in the control group. Muscle proteins have been shown to be 
involved in the increased muscle buffer capacity associated with training (Sahlin & 
Henricksson, 1984). The authors posit the BCAA supplementation may have increased 
protein anabolism or decreased protein catabolism, resulting in greater muscle protein, and 
thereby improving muscle buffer capacity. Vukovich et al. (1997) suggest that a threshold of 
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greater than 2.9 g per day BCAA supplementation may be needed to attenuate exercise-
induced increases in blood and muscle lactate accumulation.  
Alanine, a gluconeogenic precursor, has been shown to increase the secretion of 
glucagon (Brooks and Fahey, 1985). Glucagon stimulates gluconeogenesis and 
glycogenolysis. Vukovich et al. (1992), observed lower muscle glycogen content after a 
Wingate test after seven days of amino acid supplementation. They suggested the increased 
glycogen use may have been due to increased glucagon secretion in response to greater blood 
alanine concentrations, although they did not measure glucagon. Amino acid 
supplementation may potentially decrease long-term endurance performance if in fact 
glycogenolysis is stimulated, increasing the probability of athletes becoming glycogen-
depleted. However, if alanine stimulates glucagon secretion, which in turn stimulates 
gluconeogenesis, blood glucose levels may be better maintained during prolonged exercise in 
response to amino acid supplementation, decreasing the chance of athletes experiencing 
hypoglycemia. Whether glucagon secretion in response to amino acid supplementation 
mediates endurance performance has yet to be elucidated.     
Responders to BCAA Supplementation 
There may be responders and non-responders to BCAA supplementation (Maresh et 
al. 1991, 1994). Maresh et al. (1991, 1994) found participants who were more physically 
active – expending more than 1000 kcals per day – had lower plasma lactate concentrations 
after a 30-second Wingate test than those reporting daily expenditure of less than 500 kcals 
after consuming ~ 7.6 g amino acids per day for 14 days. Vukovich et al. (1997) corroborate 
this theory of responding to amino acid supplementation. They found that seven days of 
supplementation did not influence blood or muscle lactate concentrations in sedentary 
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participants expending fewer than 500 kcals per day. Thus, amino acid supplementation may 
be more likely to lower blood and muscle lactate accumulation during exercise in individuals 
who have a greater energy demand from increased physical activity.  
Need for Additional BCAA Intake 
People beginning an exercise program may have increased demands for BCAA 
consumption. When untrained people begin a physical activity program, they may be in 
negative nitrogen balance for up to ~ 21 days (Gontzea et al., 1975), indicating greater 
protein degradation than synthesis, or net protein loss. This suggests people beginning an 
endurance training program may have greater dietary protein requirements. The negative 
nitrogen balance has been improved to a greater extent with ingestion of 1.5 g protein/kg 
body mass per day than 1.0 g protein/kg mass (Gontzea et al., 1974). These findings are 
corroborated by Vukovich et al. (1997). They observed two weeks of BCAA 
supplementation resulted in less 24-hour urea excretion after the ride to exhaustion at 
120%VO2 max than two weeks of placebo. This suggests that two weeks of BCAA 
supplementation attenuates protein degradation during the early stages of combined aerobic 
and anaerobic exercise program.  
BCAA and Cognition 
The synthesis of catecholamines (dopamine, epinephrine, and norepinephrine) in the 
brain is dependent on the availability of their amino acid precursors tyrosine (Tyr) and 
phenylalanine (Phe). Administration of BCAA lowers the plasma ratio of Tyr + Phe:BCAA 
and therefore, may decrease the synthesis of catecholamines and lead to cognitive changes 
consistent with impaired dopamine activity. Scarnà et al. (2005) gave participants an amino 
acid mixture comprised of 60 g BCAA (valine 18g, isoleucine 18 g, and leucine 24 g) plus 2 
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g tryptophan or placebo. The BCAA/Trp mixture resulted in higher levels of BCAA and 
tryptophan in the plasma and decreased ratios of Tyr + Phe:BCAA and Trp:BCAA. The 
absolute levels of tyrosine and phenylalanine decreased, perhaps due to increased protein 
synthesis stimulating their uptake, caused by ingesting the amino acid mixture. The amino 
acid mixture also resulted in higher levels of prolactin. Prolactin is a hormone synthesized 
and secreted from the anterior pituitary. Dopamine inhibits prolactin synthesis. The increase 
in plasma prolactin is consistent with lower dopamine levels caused by administration of 
BCAA. Participants receiving the Trp/BCAA treatment were significantly more accurate (96 
± 32 vs. 86 ± 29% for Trp/BCAA and placebo, respectively) and faster to respond during a 
pattern recognition memory test (1645 ± 579 vs. 2163 ± 1071 ms for Trp/BCAA and 
placebo, respectively) than their counterparts receiving the placebo, for which the authors 
have no clear explanation. Participants in the Trp/BCAA group were also more likely to 
make risky choices on an experimental gamble scenario, suggesting alterations in the 
catecholamine system influence the capacity to choose actions associated with risks and 
rewards. Interestingly, participants receiving the Trp/BCAA mixture reported feeling more 
fatigue at both 270 and 330 minutes and less vigorous 330 minutes after ingestion, compared 
to those consuming the placebo, as measured by the Profile of Mood States questionnaire. 
The fact that participants reported feeling more fatigued after receiving the Trp/BCAA 
mixture is puzzling because fTrp:BCAA decreased, and according to the Central Fatigue 
Theory, one would expect fatigue to be attenuated in such a condition. The authors 
hypothesize the increase in fatigue may be caused by a decrease in catecholamine 
availability.  
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Branched-chain amino acids may either improve or prevent loss of cognitive 
performance after endurance exercise (Hassmén et al., 1994). Participants given BCAA 
during a 30-km cross-country race improved their performance by 3-7% in the different parts 
of the word-color test (words, colors and color words) after exercise, whereas no difference 
was observed before and after the race in participants given a carbohydrate placebo. 
Performance in shape-rotation and figure-identification tasks decreased after the race in 
participants receiving placebo (25 and 15%, respectively), whereas performance of these 
tasks was maintained in participants receiving BCAA. The authors suggest BCAA 
supplementation is more likely to maintain cognitive performance of more complex tasks 
than less demanding ones after endurance exercise. The effects of amino acid 
supplementation on exercise-mediated cognitive function are not fully understood and more 
research in the area is needed.      
BCAA and Physical Activity 
 Branched-chain amino acid supplementation may influence free-living voluntary 
physical activity. Through a series of studies using exercising rats, Smriga et al. (2006) tested 
the hypothesis that greater dietary intakes of BCAA may affect voluntary physical activity 
behavior. In one study, adult male rats housed in cages equipped with a running wheel were 
given one of two diets: standard laboratory diet fortified with 20 g/kg BCAA or control, 
standard laboratory diet with 20 g/kg glutamine. The group receiving the control diet ran the 
same distance each day; however, the group receiving the BCAA-fortified diet gradually 
increased their running distances. After day four, the BCAA group was running significantly 
greater distances than the control group. Whether similar results would be observed in human 
studies is unknown as behavior change is likely more complex in humans. In a second study, 
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Smriga and colleagues examined the effect of exercise on ad libitum BCAA consumption. 
Rats were housed in cages containing running wheels, a pellet dispenser, and two fluid 
dippers. One dipper contained water, the other a BCAA-based amino acid solution (15.2 
mmol/L leucine, 9.9 mmol/L isoleucine, 11.1 mmol/L valine, 16.6 mmol/L glutamine, and 
13.9 mmol/L arginine). They found that food intake was not related to running distance. Rats 
running > 1500 m during the dark period (1900-700 h) consumed significantly more BCAA 
solution than water. The authors concluded from these studies that BCAA intake and 
physical activity in rats are related. When the physical activity of rats increased, so did their 
voluntary consumption of BCAA and when rats were fed greater amounts of BCAA, they 
voluntarily increased their physical activity. One should note, in the second study, the fluid 
dippers contained either water or BCAA. These two treatments are not isocaloric, so it could 
be posited that rats chose to drink more BCAA solution to increase their caloric intake to 
compensate for greater energy expenditure. A follow-up study is warranted to distinguish the 
contribution of BCAA per se, or their caloric content. Furthermore, a study examining the 
effects of BCAA supplementation on free living voluntary physical activity in humans is 
highly warranted. 
Leucine Supplementation and Obesity 
Branched-chain amino acids may mediate body mass regulation and blood lipid 
profiles. Donato et al. (2006) found that leucine supplementation during caloric restriction 
increased fat loss and improved protein synthesis in muscle and liver in rats. Zhang et al. 
(2007) conducted a study in which they fed mice one of four diets for 14 weeks: regular 
rodent chow, regular rodent chow supplemented with leucine, high-fat diet, or high-fat diet 
supplemented with leucine. Leucine supplementation increased plasma leucine 
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concentrations, but decreased overall plasma amino acids levels, suggesting a decrease in 
protein catabolism. Leucine supplementation significantly attenuated the body mass gain 
(32% less) and increased adiposity (25% less) observed in mice consuming high-fat diets, 
despite similar total caloric intakes between the high-fat diet groups. The mice consuming the 
high-fat diet supplemented with leucine had greater total energy expenditure than the high-fat 
diet group. Furthermore, the respiratory exchange ratio (RER) was lower in mice consuming 
the leucine-supplemented high-fat than those consuming the high-fat diet, suggesting greater 
fat oxidation from leucine supplementation. Additionally, increasing leucine intake improved 
glucose tolerance (34.2 ± 7.6 vs. 67.7 ± 11.7 homeostasis model assessment of insulin 
resistance index for the leucine and control groups, respectively) and insulin sensitivity in 
mice fed high-fat diets. Forward-stepwise regression indicated that the glucose-lowering 
effect of leucine was independent of the decrease in adiposity. Leucine supplementation for 
14 weeks decreased total cholesterol 27% and LDL-cholesterol 53% in high-fat diet mice. 
However, leucine had no effect on HDL-cholesterol, total triglycerides, or free fatty acid 
concentration. Leucine had no noteworthy effect on mice consuming the normal rodent chow 
diets. 
Supplementation of BCAA (76% leucine) during periods of caloric restriction may 
result in greater body weight mass loss, decrease in percent body fat, and preferential 
reduction in abdominal visceral adipose tissue, as observed in competitive wrestlers 
(Mourier, et al., 1997). Additionally, during periods of caloric restriction, no change in 
aerobic (VO2 max) or anaerobic (Wingate test) capacities and muscular strength were 
observed. These results suggest BCAA supplementation during periods of moderate caloric 
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restriction augments preferential visceral adipose loss while maintaining a desirable, high 
level of performance.    
Lateral hypothalamic 5-HT activity is inversely related to food intake (Leibowitz et 
al., 1990); decreases in hypothalamic 5-HT activity increases food intake. Branched-chain 
amino acid supplementation may decrease neural 5-HT activity, potentially mediating 
voluntary food intake. Cota et al., (2006) found that central administration of leucine to the 
third ventricle of the brain decreased food intake and body weight. However, based on the 
findings of their behavioral studies in which food intake was unaffected by ad libitum BCAA 
access, Leibowitz et al., (1990) suggest BCAA may not be centrally involved in influencing 
feeding behaviors. 
BCAA and Muscle Recovery 
Some studies have shown that BCAA supplementation may enhance recovery after 
strenuous exercise. Sugita et al. (2003) had male students perform a session of eccentric 
exercise training. During ten days of recovery, participants consumed an amino acid mixture 
(5.6g; ~30% by weight BCAA, 14% glutamine, 14% arginine, threonine, lysine, proline, 
methionine, histidine, phenylalanine, and tryptophan plus vitamins and minerals) or 
isocaloric placebo (vitamins and minerals plus carbohydrate) twice per day. Ingestion of the 
amino acid mixture accelerated recovery from eccentric exercise. Whereas force production 
decreased in both groups after eccentric exercise, maximal isometric force production during 
elbow extension was greater in the amino acid group than the placebo group. Interestingly, 
no treatment effect was observed for elbow flexion.  
The group also conducted a dose-response study to examine the effective dose for 
reducing training-induced muscle damage (Ohtani et al., 2001). Middle- and long-distance 
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college male track athletes consumed 2.2, 4.4, and 6.6 g/day of the previously described 
amino acid mixture for one month. A one-month washout period between treatments was 
given. Level of training was maintained constant during the six months by altering running 
distance and intensity. Blood samples were taken in a fasted state one day after no physical 
activity before and after each one-month treatment period. The 2.2 g/day dose did not affect 
blood measures of damage and oxygen-carrying capacity. The 4.4 g/day dose increased 
serum albumin and reduced serum iron and blood lactate concentrations. The 6.6 g/day dose 
produced significant changes in oxygen-carrying capacity, physical condition, and blood 
markers of muscle damage. Blood glucose concentrations were greater after one month 
supplementation of 6.6 g/day amino acid mixture (88 ± 1 and 93 ± 1 mg/dl pre- and post-test, 
respectively), suggesting increased glycogenesis, according to the authors. Red blood cell 
count, hemoglobin concentration, and percent hematocrit increased after one month 
supplementation of 6.6 g/day, suggesting an increase in hematopoiesis and oxygen-carrying 
capacity. One month of 6.6 g/day amino acid supplementation resulted in higher self-
assessed physical condition scores, greater serum albumin concentrations, lower CPK, or 
LDH. The lower CPK activities suggest faster recovery from training-induced inflammation. 
Coombes et al. (2000) found that 40 g BCAA (approximately 550 mg/kg body mass) reduced 
muscle damage after prolonged endurance exercise. The exercise-induced muscle protein 
breakdown may be attenuated by BCAA supplementation before and during prolonged 
exercise (MacLean et al., 1994; MacLean et al., 1996), mediating exercise-induced muscle 
damage. 
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Safety of BCAA Consumption 
High doses of BCAA may have negative effects. The recommended daily protein 
intake is 0.8 g/kg body mass for adults and 1.2 to 1.8 g/kg body mass for athletes 
(Jeukendrup & Gleeson, 2004). High daily protein intake (> 3 g/kg body mass) may cause 
dehydration, increased blood lipoprotein levels, and potentially kidney failure (Gleeson, 
2005). Plasma ammonia concentrations may increase when participants are given large 
amounts of BCAA (20-30 g) before or during exercise (Wagenmakers, 1992; MacLean and 
Graham, 1993; van Hall et al., 1995; MacLean et al., 1994). However, others have observed 
no increase in ammonia after BCAA administration before or during exercise (Varnier et al., 
1994; Blomstrand et al., 1997; Mittleman et al., 1998). Smaller doses of BCAA (7-10 g; 100 
mg/kg/body mass) do not stimulate release of ammonia from muscles (Blomstrand et al., 
1997). According to Gleeson (2005), daily intakes of 10-30 g BCAA do not appear to be 
harmful. More precisely, daily intakes of up to 450 mg/kg body mass of BCAA appear to be 
well tolerated in healthy adults (Gleeson, 2005). A dose-response study of BCAA 
supplementation dose, measures of physical performance, alterations in the ratio of plasma 
fTrp/BCAA, and plasma ammonia concentrations is warranted (Crowe et al., 2006).  
Supplementation of BCAA for one month does not appear to have adverse effects on 
liver function. Ohtani et al. (2001) found that one month of 6.6 g/day amino acid 
supplementation resulted lower glutamate-oxaloacetate transferase (GOT) activity. 
Supplementation did affect activities of GPT, or γ-glutamyltranspeptidase (GTP). GOT, 
GPT, and γ-GTP are markers of liver function; greater activities suggest disturbance of liver 
function and or states of liver disease. In fact, BCAA supplementation to liver cirrhosis 
patients decreased the activity of alkaline phosphatase, another marker of liver damage (Suga 
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et al., 1994). These findings suggest no adverse liver function consequences result from 
amino acid supplementation. However, controlled long-term studies examining the effects of 
amino acids supplementation on kidney and liver function are highly warranted. 
BCAA Summary 
The three branched-chain amino acids – leucine, isoleucine, and valine have been 
shown to positively affect several measures in human and animal studies. The efficacy of 
BCAA supplementation on exercise performance has been posited to depend on several 
factors including the mode of administration (Verger et al., 1994), the nutritional status of 
recipients (Calders et al., 1997), use in conjunction with carbohydrates (Blomstrand, 2001), 
and the length and intensity of exercise (Strüder et al. (1998). Blomstrand (2001) argues that 
the benefits of BCAA use are likely to be greater during activities in which the central 
component of fatigue plays a considerable role, such as exercise in the heat or during a 
competitive race. Branched-chain amino acids may limit central fatigue by competing with 
free-tryptophan for uptake into the brain via the same transport mechanism (Blomstrand et 
al., 1997; Pardridge and Oldendorf, 1975). Branched-chain amino acids supplementation has 
been shown to decrease perceived exertion and increase endurance performance (Blomstrand 
et al., 1991, 1997) and reduce brain serotonin synthesis (Gomez-Merino et al., 2001;Smriga 
et al. 2006). Whereas research has shown that BCAA supplementation may attenuate 
exercise-induced fatigue, some studies fail to corroborate these findings (Strüder et al., 1998; 
Wagenmakers, 1992; Varnier et al., 1994). Branched-chain amino acid supplementation may 
improve muscle buffering capacity (Vukovich et al. (1997). Increased BCAA availability has 
been shown to increase the transamination of pyruvate to alanine (Odessey et al., 1974), 
thereby decreasing lactate formation (Mole et al., 1973), potentially ameliorating the onset of 
40 
 
fatigue. Vukovich et al. (1992) found that seven days of supplementation with an amino acid 
mixture (0.8 g/kg body mass; rich in BCAA) significantly lowered participants’ blood lactate 
concentrations when they exercised at intensities greater than 100% VO2 max. Infusion of 
BCAA, particularly leucine, has been shown to increase protein synthesis (Alvestrand et al., 
1990) and decrease protein breakdown (Louard et al., 1990; Nair et al., 1992), potentially 
resulting in net protein accretion. 
Branched-chain amino acid supplementation may have health benefits. Consumption 
of BCAA influences free-living voluntary physical activity (Smriga et al. (2006). Leucine 
supplementation for 14 weeks improved glucose tolerance, lowered total cholesterol, and 
LDL-cholesterol in high-fat diet mice (Zhang et al., 2007). Supplementation of BCAA (76% 
leucine) during periods of caloric restriction may result in greater body weight mass loss, 
decrease in percent body fat, and preferential reduction in abdominal visceral adipose tissue, 
as observed in competitive wrestlers (Mourier, et al., 1997). Finally, supplementation of 
BCAA (6.6 g/d) for one month does not appear to have adverse effects on liver function 
(Ohtani et al., 2001). More research is needed on the long-term effects of consuming high 
protein diets or amino acids supplements.  
Carbohydrate mouth rinse 
Carbohydrate ingestion before and during short-term and intense exercise sessions 
has been shown to delay fatigue and improve exercise (Bergstrom et al., 1967; Coggan & 
Coyle, 1987; Foskett et al., 2008). The mechanism underlying reported enhancement is not 
well understood. One theory suggests carbohydrate feeding may enhance rates of 
carbohydrate oxidation. However, for short-term, high-intensity exercise bouts, this theory 
may be unlikely as only 5 to 22 grams of exogenous carbohydrates are oxidized in the first 
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hour of exercise, minimally contributing to total carbohydrate oxidation rates, and an amount 
possibly too small to significantly enhance exercise performance (Jeukendrup et al., 1997). 
Additionally, some have reported no difference in rates of carbohydrate oxidation during 
high intensity exercise when given carbohydrates or placebo (Neufer et al., 1987; Below et 
al., 1995). Furthermore, muscle glycogen contributes much more carbohydrates for oxidation 
than does the liver or blood during one hour of exercise. Others have demonstrated that 
carbohydrate feeding before and during exercise bouts does not enhance performance 
(Palmer et al., 1998; Clark et al., 2000). Carbohydrate ingestion has been shown to improve 
performance when muscle glycogen stores become depleted, which usually occurs during 
longer duration exercise bouts (Coyle et al., 1986). Hawley et al. (1997) demonstrated that 
after one hour of all-out cycling, adequate glycogen remains in the muscle. Whereas no clear 
metabolic explanation exists for improved exercise performance when given a carbohydrate 
solution, the general consensus is that carbohydrate feeding likely improves exercise 
performance.  
Prolonged exercise bouts deplete muscle glycogen content, which can decrease 
exercise performance. Feeding carbohydrate before and during exercise may improve 
performance and delay fatigue. Ingestion of carbohydrate increases glucose metabolism in 
the muscle, leading to a slower rate of glycogen depletion (Tsintzas et al., 1996). However, 
carbohydrate ingestion has been shown to improve exercise performance independent of 
muscle glycogen sparing (Coyle et al., 1986). Others have shown carbohydrate ingestion 
does not influence carbohydrate oxidation, muscle metabolism, or exercise performance 
while exercising to fatigue (McConell et al., 2000). Furthermore, a relatively small 
percentage (26%) of total carbohydrate ingested enters the peripheral circulatory system 
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during high-intensity endurance exercise (McConell et al., 2000). However, several studies 
have shown that carbohydrate ingestion improves exercise performance without influencing 
muscle metabolism (Anantaraman et al., 1995; Powers et al., 1990)  
Whereas it is generally accepted that carbohydrate ingestion improves exercise 
performance during prolonged exercise bouts in which glycogen depletion may occur, the 
effects of carbohydrate ingestion on exercise performance in shorter-term bouts are less well 
understood. Neufer et al. (1987) found that carbohydrate ingestion (45g) by well-trained 
cyclists increases the total amount of work performed in 15 minutes by approximately 10% 
after cycling for 45 minutes at 77% VO2 max. The mechanism for the improvement in short-
term exercise bouts from carbohydrate ingestion has yet to be fully elucidated. Some have 
suggested that greater rates of carbohydrate oxidation may be implicated in increased 
performance; however, it has been demonstrated that no difference in carbohydrate oxidation 
rates exists during 45-60 minutes of exercise between a carbohydrate ingestion trial and 
placebo (Neufer et al., 1987; Below et al., 1995).  
Central or non-metabolic factors may mediate improvements in performance in 
response to carbohydrate consumption. Carter et al. (2004a) found that whereas glucose 
infusion (one g/min) resulted in abundant available circulating glucose, infusion did not 
improve performance in a simulated 40 km time trial bout. The group suggests that oral 
carbohydrate feeding may exert its effects through a central mechanism, improving motor 
drive or motivations, mediated by receptors in the mouth or gastrointestinal (GI) tract. 
To test the hypothesis that receptors in the mouth may stimulate a central drive 
mechanism, Carter et al. (2004b) had participants rinse the mouth with either a carbohydrate 
solution (6.4 % maltodextrin) or water and without swallowing, spit out the treatment, thus 
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eliminating potential stimulation from GI tract receptors to induce a metabolic action. 
Participants were asked to complete a given amount of work (0.75 x W x 3600) as quickly as 
possible. This time trial procedure is highly reproducible when performed in this way using 
participants who are experienced in this type of exercise (Jeukendrup et al., 1996). 
Participants were given a 25-ml bolus of carbohydrate solution or water every 12.5% of the 
time trial completed, which was rinsed around their mouths for approximately five seconds 
and spat into a bowl held by an investigator. Participants were informed that both treatments 
had been previously reported to improve exercise performance. Time to complete the 
performance trial was significantly less (2.9%) when participants rinsed with carbohydrate 
compared to water. Power output was therefore greater when participants rinsed with 
carbohydrate. Furthermore, mean power output was greater during the first three-fourths of 
the trial when receiving the carbohydrate rinse than the water rinse. There were no 
differences in heart rate, ratings of perceived exertion, or body mass changes between the 
treatment groups. Five of the nine participants were unable to distinguish between the 
treatments. The four who correctly identified treatment reported a different feel or viscosity 
between the carbohydrate and water solutions. 
The mechanism for time trial improvement when rinsing with or ingestion of a 
carbohydrate solution is unclear. There may be “nonmetabolic” or central mechanisms 
involved. One hypothesis is that ingestion of carbohydrate may increase circulating glucose 
concentrations, thereby improving glucose availability to the brain, enhancing central 
nervous system functioning. When rinsing with carbohydrates, increased glucose delivery to 
the brain is not likely. A second hypothesis is that ingestion or rinsing with carbohydrates 
activates receptors in the mouth that stimulate an afferent pathway to the brain. Carter et al. 
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(2004b) suggested that oral cavity receptors may stimulate reward centers of the brain. 
Glucose receptors are well known to exist in the gut and brain of humans. Additionally, 
various taste receptors exist in the oral cavity of humans, including those that sense sweet 
foodstuffs on the tongue. However, because maltodextrin is not a sweet carbohydrate, it is 
unlikely that sweet receptors signal the brain in the study by Carter et al. Rats may have 
receptors for polycose, a partially hydrolyzed, non-sweet carbohydrate similar to 
maltodextrin (Nissenbaum & Scalafani, 1987). Furthermore, polysaccharide receptors are 
known to exist in several species including rats, gerbils, mice, and hamsters (Feigin et al., 
1987). It is currently unknown if such receptors exist in humans.  
According to Katz et al. (2000), humans possess what is called the “mouth feel 
phenomenon.” Humans are able to differentiate viscosity and feel of foodstuffs in the mouth, 
stimulating cortical taste neurons and orbitofrontal cortex neurons. Studies using 
neuroimaging have demonstrated that oral ingestion of glucose stimulates the primary taste 
cortex and the putative secondary taste cortex of the orbitofrontal cortex. The primary taste 
cortex and orbitofrontal cortex are thought to have projections to the reward and behavior 
centers of the brain – the dorsolateral prefrontal cortex, the anterior cingulated cortex, and 
ventral striatum (Rolls, 2007). These brain regions, when activated, may influence emotion 
and behavior, thereby potentially influencing exercise performance (Kringelbach, 2004). 
Carter and colleagues (2004b) therefore suggested that non-sweet receptors may exist in the 
human mouth capable of initiating a centrally mediated effect on exercise performance. 
Chambers et al., (2009) recruited competitive or recreational cyclists (six males, two 
females) to determine the effects of oral glucose and oral maltodextrin on exercise 
performance. Participants were given 6.4% glucose, maltodextrin, or placebo at the start of 
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exercise and each 12.5% of time trial (equal to one hour at 75% maximum power output) 
completion and instructed to rinse the mouth for approximately ten seconds and spit the 
solution into a bowl held by an investigator. Subjective appraisal of sweetness and viscosity 
were assessed by visual analog scales with an anchor point at 0mm labeled “Nil” and 100mm 
labeled “Extreme.” Participants rated no difference between glucose and placebo solutions 
for sweetness, but did rate the glucose solution as more viscous. Participants completed the 
same amount of work during the performance trial in less time during the glucose trial than 
the placebo trial (60.4 ± 3.7 vs. 61.6 ± 3.8 min, respectively). Average power output was 
higher during the glucose trial than the placebo trial. Treatment had no effect on ratings of 
perceived exertion or heart rate. For the maltodextrin study, no differences in ratings of 
sweetness and viscosity were found between the maltodextrin and placebo solutions and 
subjects were able to differentiate between solutions. Participants completed the performance 
trial faster when receiving the maltodextrin solution than when receiving the placebo solution 
(62.6 ± 4.7 vs. 64.6 ± 4.9 min, respectively). Treatment had no effect on ratings of perceived 
exertion or heart rate during the performance trial.  
During cycling time trials, there is a trend for decreasing power output during the trial 
until a final sprint to the finish, during which power output is higher. Accordingly, 
participants alter their power outputs to maintain a relatively consistent perception of 
exertion (Cole et al. 1996). Chambers et al. (2009) suggested that oral exposure to 
carbohydrate induces a central response that allows participants to increase power output by 
reducing perception of a given workload. The authors suggest that improvements in exercise 
performance were independent of the sweetness of treatments.  
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Chambers et al., (2009) also examined the regions of the brain activated by in 
response to glucose, maltodextrin, and the artificial non-caloric sweetener, saccharin entering 
the mouth. To assess activated brain regions, they used functional magnetic resonance 
imaging to determine the blood oxygenation level-dependent responses to different solutions 
in the mouth. A plastic tube connected to a reservoir via a syringe and a two-way tap, 
allowed 2.5 ml of solution to be delivered to the participants. After a ten-second rest period, 
2.5 ml of solution was delivered to the mouth. Participants were instructed to make one 
tongue movement to distribute the solution in the oral cavity, and swallow the solution after 
ten seconds of solution being in the oral cavity. After an 18-second rest period, control 
solution (25 mmol KCL and 2.5 mmol NaHCO3 in distilled water) was delivered. The 
participants were instructed to swallow (within two seconds) again after ten seconds had 
elapsed. Each of the 12 trials lasted 52 seconds. Oral exposure to glucose resulted in 
activation of insula/frontal operculum (the putative human primary taste cortex), the left and 
right areas of the dorsolateral prefrontal cortex (a region of the right caudate that forms part 
of the striatum; believed to be involved in preparation and selection of cognitive responses 
induced by taste stimuli), and an anterior area of the cingulated cortex. Oral exposure to 
saccharin evoked activation of the insula/frontal operculum and the left dorsolateral 
prefrontal cortex. In contrast to oral glucose exposure, oral saccharin exposure did not result 
in activation of the anterior cingulate cortex or striatum. A conjunction overlay mask was 
created to examine cortical regions that were activated by both caloric (glucose) and non-
caloric sweetened (saccharin) solutions. An area of the right insula/frontal operculum and a 
region of the left dorsolateral prefrontal cortex were responsive to both glucose and saccharin 
solutions. Oral exposure to glucose in the second study resulted in activation of the 
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insula/frontal operculum, an area of the medial orbitofrontal cortex that extended into the 
bordering anterior cingulated cortex, the dorsolateral prefrontal cortex, a more dorsal region 
of the anterior cingulate cortex, and the left and right caudate. Oral exposure to maltodextrin 
resulted in activation of the insula/frontal operculum, medial orbitofrontal cortex that 
extended into an adjoining rostral part of the anterior cingulate cortex, the dorsolateral 
prefrontal cortex, and the right caudate. Oral exposure to maltodextrin did not activate the 
dorsal regions of the anterior cingulate cortex, unlike oral exposure to glucose. A conjunction 
overlay mask showed that the right insula/frontal operculum and a small area in the left 
frontal operculum, the medial orbitofrontal cortex, the dorsolateral prefrontal cortex, and the 
right caudate and rostral anterior cingulate cortex were activated by both glucose and 
maltodextrin taste.   
Oral glucose exposure activated regions of the brain that were unaffected by oral 
saccharin exposure, including the anterior cingulate cortex and the right caudate, that forms 
part of the striatum, regions believed to influence the emotional and behavioral responses to 
rewarding food stimuli (Berridge & Robinson, 1998; Kelley et al., 2002; Rolls, 2007). This 
supports the idea that sweetness is not a requisite for activation of reward centers of the 
brain. De Araujo & Rolls (2004) observed that a rostral portion of the anterior cingulate 
cortex is activated in response to oral fat, suggesting these regions of the brain are stimulated 
in response to the energy content of food. Chambers et al. (2009) suggested that perhaps the 
caloric content of sugars may be responsible for such activation because similar cortical 
activation (primary taste cortex and a medial region of the orbitofrontal cortex, the putative 
secondary taste cortex) was produced by oral exposure to glucose and maltodextrin despite 
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differences in solutions sweetness. The orbitofrontal cortex is considered to be the hedonic 
value region of the brain stimulated in response to an oral stimulus.   
This study showed that a non-sweet carbohydrate and glucose in the mouth produced 
similar cortical activation. This finding suggest that unidentified oral receptors may exist that 
respond to the caloric property of carbohydrate, independent of carbohydrate sweetness 
properties. The authors corroborate the findings of Carter et al. (2004b) and concluded that 
presentation of carbohydrate to the oral cavity improves exercise performance during a one-
hour cycle time trial. Both studies examined the brain regions activated by oral glucose 
exposure and some small differences were found. In the second study, glucose activated the 
orbitofrontal cortex and the adjoining rostral part of the anterior cingulate cortex. These areas 
were not activated by oral glucose exposure in the first study.  
According to Berridge and Robinson (1998), the dopaminergic system of the ventral 
striatum is involved in arousal, motivation, and motor behavior. During exercise, much 
afferent information from muscles, joints, lungs, skin, and core body temperature receptors is 
sent to the brain, which may be perceived as unpleasant, leading to an inhibition of motor 
output, leading to central fatigue. The “Central Governor Model” of fatigue suggests that 
during physical activity, people likely modify their level of exertion to maintain an 
acceptable comfort level (Noakes, 2000; Lambert et al., 2005). Whereas the exact neural 
pathways are not defined in such central fatigue, if reward centers are inhibited during 
prolonged exercise, it is possible that presentation of foods to the oral cavity may attenuate 
inhibition of these regions, thereby improving exercise performance.  
The major limitations of the studies by Chambers et al. (2009) are that functional 
imaging of the brain was not performed in exercise, but at rest. Perhaps the reward centers of 
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the brain activated while swilling the mouth with a carbohydrate solution at rest are not 
stimulated during exercise. Additionally, the mouth rinse solutions used in the functional 
imaging study had about three times the carbohydrate concentration as the solutions used in 
the exercise performance study. Therefore, it is difficult state that the mouth rinse solutions 
in the exercise performance study would stimulate behavior centers of the brain.  
Studies have shown that runners feel better and report lower ratings of perceived 
exertion when ingesting carbohydrates during exercise (Backhouse et al., 2007; Backhouse et 
al., 2005). However, Whitham and McKinney (2007) showed that simply tasting a 
carbohydrate solution by rinsing the mouth without swallowing did not alter ratings of 
perceived exertion during a 45-minute running time trial. A major limitation of the study by 
Whitham and McKinney is that running speed could not be easily adjusted; a researcher or 
participant had to manually adjust treadmill speed. Therefore, Rollo et al. (2008) tested the 
effects of rinsing the mouth with a carbohydrate solution (6% carbohydrate) on self-selected 
running speeds in endurance-trained runners utilizing an automated treadmill that allows free 
and spontaneous adjustments to running speed without manual input. The running protocol 
was a ten-minute warm-up at 60% VO2 max followed by a 30-minute trial in which the 
participants were asked to maintain a running speed equal to a “hard pace” or an RPE of 15. 
The treadmill had a 1% grade for the entire 40 minutes. Runners were free to adjust their 
running speed using the automated system. Participants were given a 25 ml bolus of 
treatment every five minutes during the 30-minute run with which they rinsed their mouths 
for five seconds and expectorated. Feeling Scale (FS), Felt Arousal Scale (FAS), and 
Gastrointestinal comfort (GI) scales were administered every five minutes during the 30-
minute run. No differences were found in heart rate, body weight loss, rating of perceived 
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activation (FAS), and gastrointestinal comfort during the 30-minute run between rinsing the 
mouth with 6% carbohydrate solution and rinsing with placebo. At the start of the run, 
feeling score was higher in the carbohydrate trial, but no differences were found for the 
remainder of the run. Self-selected speed was faster in the first five minutes of the 
carbohydrate mouth rinse trial than the placebo mouth rinse trial. Additionally, participants 
ran farther during the carbohydrate mouth rinse trial than the placebo trial (6584 ± 520 vs. 
6469 ± 515 m, respectively). Interestingly, rinsing the mouth with carbohydrate resulted in 
significantly greater estimated energy expenditure than rinsing with placebo (493 ± 54 vs. 
485 ± 55 kcal, respectively).  
Rinsing the mouth with carbohydrates may lower perception of exertion at a given 
exercise intensity. The participants in the Carter et al. (2004b) study had greater average 
power output with no increase in ratings of perceived exertion when rinsing with a 
carbohydrate solution, compared to placebo. Similarly, participants in the Rollo et al. (2008) 
study were able to run faster while maintaining a rating of perceived exertion of 15 or “Hard” 
when rinsing with a carbohydrate solution than placebo. Rollo et al. (2008) suggested that 
carbohydrate presentation to the mouth may result in a “feel good” effect. Furthermore, 
recognition of carbohydrates in the mouth might relay signals of incoming energy to the 
brain, resulting in increased motor behavior or exercise performance. Additionally, 
recognition of carbohydrates in the mouth may result in a transient increase in psychological 
response towards exercise. However, when the brain receives feedback that no additional 
energy is available, both motor behavior and psychological feelings may be adjusted 
accordingly. Therefore, it may be important to rinse the mouth at given intervals. The time-
course of such responses has yet to be elucidated.     
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Pottier et al. (2008), found that rinsing the mouth with a commercially available 
carbohydrate-electrolyte solution resulted in a significantly shorter time to complete a time 
trial equal to one hour of pedaling at participants’ preferred pedaling cadence than rinsing 
with placebo. Interestingly, ingestion of the carbohydrate-electrolyte solution did not affect 
time trial performance. Pottier et al. (2008) found that participants had higher mean power 
output during the self-paced cycling time trial, resulting in less time to complete a given 
amount of work, higher blood lactate, and no difference in heart rate or ratings of perceived 
exertion when participants rinsed the mouth with a carbohydrate-electrolyte solution, 
compared to a placebo. Furthermore, rinsing of a carbohydrate-electrolyte solution allows 
participants to exercise at a higher power output for a given subjective evaluation of exertion. 
Rinsing the mouth with the carbohydrate-electrolyte solution resulted in higher blood lactate 
concentrations than rinsing with placebo. Ingestion of the carbohydrate-electrolyte solution 
resulted in significantly greater blood glucose than ingestion of placebo. There was no 
difference in blood glucose between rinsing the mouth with carbohydrate-electrolyte solution 
or placebo. A trend for higher blood glucose (P = 0.06) was observed for intake mode; blood 
glucose tended to be higher when the treatments were ingested, compared to rinsed.  
The carbohydrate-electrolyte solution in the study by Pottier et al. (2008) was 
comprised of a mixture mono- and disaccharide carbohydrates, suggesting that both simple 
and complex carbohydrates in the oral cavity result in improved exercise performance. The 
authors hypothesize that presentation of carbohydrates to the mouth may attenuate afferent 
signals of fatigue from the contracting muscle, allowing participants to produce more power 
at a given level of perceived exertion. The exact mechanism is yet to be elucidated, but the 
authors suggest that afferent signals from carbohydrate receptors in the oral cavity may 
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attenuate afferent signals from the muscle to the brain. During fatiguing exercise, several 
neuroendocrine changes occur in the brain. Changes in enkephalinergic, dopaminergic, and 
serotonergic systems occur during fatiguing exercise (Hoffman et al., 1990; Bailey et al., 
1993; Persson et al., 1993; van Hall et al., 1995). These neuroendocrine changes likely 
influence motivation, and pain and its tolerance, according to Gandevia (1998), thereby 
potentially influencing central fatigue. Because they observed improved performance during 
the rinsing of carbohydrates trial and not the ingestion of carbohydrates trial, Pottier et al. 
(2008) suggested the shorter duration of carbohydrate spent in the oral cavity during the 
ingestion trial may have decreased the ergogenic effects of carbohydrate presentation to the 
oral cavity.  
To test the effects of carbohydrate mouth rinse on performance in a practical applied 
setting, Beelen et al. (2009) assessed mouth rinsing during a cycling time trial in the fed 
state. Participants consumed a meal containing 39.5 ± 0.8 kJ/kg (67% carbohydrate, 13% 
protein, 20% fat energy basis), providing 2.36 ± 0.04 g/kg carbohydrate, 2.25 hours before 
the time trial. Participants rinsed the mouth with 25 ml of carbohydrate (6.4% maltodextrin) 
or placebo (water) for five seconds at the start and every 12.5% of the time trial completed. 
Time trial performance did not differ between carbohydrate mouth rinse and placebo mouth 
rinse. Heart rate, RPE, and body mass loss did not differ between treatments. Because RPE 
was unaffected by carbohydrate mouth rinse, the authors refute the hypothesis that rinsing the 
oral cavity with carbohydrate stimulates pleasure and reward centers of the brain. The 
authors suggest that putative glucose receptors in the mouth may be more important or 
influential during states of glycogen depletion and less important during states of adequate 
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glycogen stores, hence the lack of effect of benefit of carbohydrate mouth rinsing observed in 
the present study. 
Cephalic Phase of Insulin Release 
The cephalic phase of insulin release (CPIR) has been demonstrated in animals and 
humans. The β-cells of the pancreas will secrete insulin before the increase in plasma 
glucose. The cephalic phase of insulin secretion is a parasympathetic reflex caused by the 
sight, smell, and taste of food and is of cephalic origin. The response to taste also involves 
afferent signals to the central nervous system and actions that prepare the body for caloric 
consumption. Plasma insulin concentrations typically rise within two minutes, peak at four 
minutes, and return to baseline within ten minutes after oral stimulation (Teff & Engelman, 
1996; Teff et al., 1991; Teff et al., 1993). Placing sour (acetic acid, 0.1M), salty (NaCl, 0.5 
M), bitter (quinine hydrochloride, 0.01 M), and umami (sodium glutamate, 0.2 M) tasting 
treatments on the tongues of rats for 45 s did not affect plasma glucose or insulin 
concentrations (Tonosaki et al. 2007). Tonosaki et al. (2007) also observed that sucrose, a 
sweet, caloric carbohydrate increased plasma insulin concentrations before the rise in plasma 
glucose (three vs. five min-post presentation, respectively). Saccharin, a sweet, non-caloric 
sugar substitute, increased plasma insulin concentrations without affecting plasma glucose 
levels. Finally, starch, a caloric, non-sweet carbohydrate, had no effect on plasma insulin or 
glucose concentrations. The findings of Tonosaki et al. (2007) suggest that stimulating the 
oral cavity with sweet, caloric-containing carbohydrates stimulates the CPIR in rats before an 
increase in plasma glucose; stimulation with sweet, non-caloric substances stimulates the 
CPIR without affecting plasma glucose concentrations; stimulation with non-sweet, caloric-
containing substances does not stimulate the CPIR or affect plasma glucose concentrations. 
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Just et al. (2008) examined the effects of rinsing the mouth for 45 s and spitting out solutions 
on plasma glucose and insulin in humans. They found that intra-oral stimulation with sour, 
salty, bitter, and umami taste qualities did not elicit the CPIR. They also observed that intra-
oral stimulation of both sucrose and saccharin (sweet substances) resulted in a transient 
increase in plasma insulin five min after stimulation, without affecting plasma glucose 
concentrations. The group also observed an increase in plasma insulin after rinsing the mouth 
with distilled water and starch. However, they posit the results were greatly influenced by 
outliers, whereas the increase in insulin after rinsing with sucrose and saccharin was 
observed in all participants. Robertson et al. (2001), found that 15 minutes of chewing 
nutrients without swallowing resulted in an increase in plasma insulin of that peaked at 250% 
of baseline concentration. It is possible that rinsing the mouth with a carbohydrate solution 
increases insulin secretion and subsequent glucose uptake into muscle cells for oxidation, 
thereby enhancing time trail performance. However, the effects of rinsing the mouth with 
carbohydrates on insulin secretion during exercise have yet to be studied.  
Mouth Rinse Summary 
Carbohydrate (CHO) ingestion during prolonged exercise bouts may improve 
performance when glycogen stores become depleted. However, during shorter-term bouts, 
the mechanism for improvements observed in response to CHO ingestion is not known. 
There may be central or nonmetabolic factors involved. Glucose infusion (one g/min) did not 
improve performance in a 40 km time trial bout (Carter et al., 2004a). The group suggested 
that oral carbohydrate feeding may exert its effects through a central mechanism, improving 
motor drive or motivations, mediated by receptors in the mouth or gastrointestinal (GI) tract 
To test the hypothesis that receptors in the mouth may stimulate a central drive mechanism, 
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Carter et al. (2004b) had participants rinse the mouth with either a carbohydrate solution (6.4 
% maltodextrin). Time to complete the performance trial was significantly less (2.9%) when 
participants rinsed with carbohydrate compared to water. Carter and colleagues (2004b) 
therefore suggested that non-sweet receptors may exist in the human mouth capable of 
initiating a centrally mediated effect on exercise performance. Chambers et al. (2009) 
showed that a non-sweet carbohydrate (maltodextrin) and glucose in the mouth produced 
similar cortical activation at rest and both improved exercise performance. These findings 
suggest that unidentified oral receptors may exist that respond to the caloric property of 
carbohydrate, independent of carbohydrate sweetness properties. These functional imaging 
studies of the brain examined resting participants. Perhaps the brain reward centers activated 
while swilling the mouth with a carbohydrate solution at rest are not stimulated during 
exercise. Additionally, the mouth rinse solutions used in the functional imaging study had 
~three times the carbohydrate concentration as the solutions used in the exercise performance 
study. The cephalic phase of insulin release (CPIR) has been observed in animals and 
humans. The β-cells of the pancreas secrete insulin before an increase in plasma glucose. 
Oral cavity stimulation with sweet, non-caloric substances stimulates CPIR without affecting 
plasma glucose concentrations. Finally, oral cavity stimulation with non-sweet, caloric-
containing substances does not stimulate the CPIR or affect plasma glucose concentrations 
(Tonosaki et al., 2007). Taken together, these results suggest that mouth rinsing with both 
sweet and non-sweet solutions may improve performance owing to activation of brain centers 
responsible for motor output and drive. Additionally, enhancement of exercise performance 
from mouth rinsing with sweet solutions may involve insulin secretion.  
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Abstract 
Previous research suggests that mouth rinsing carbohydrates (CHO) improves 
exercise performance. The mechanisms for the improvement are not yet known, but may 
involve maintenance of insulin concentrations during exercise or attenuation of centrally-
mediated fatigue from putative, caloric-responsive receptors in the oral cavity. The purpose 
of this study was to determine the effects of mouth rinsing branched-chain amino acids 
(BCAA) or CHO on cycle time trial performance, blood markers of central fatigue 
(prolactin), plasma insulin, glucose, and lactate concentrations, substrate oxidation during 
steady-state exercise, and the subjective exercise experience. Ten healthy, endurance-trained 
adult males (23.5 ± 3.8 y, 74.0 ± 9.0 kg, 180.5 ± 5.4 cm, 57.9 ± 6.9 ml/kg/min VO2 peak) 
volunteered for the study. Participants exercised at 65% Wattmax for 30 min then completed a 
time trial equivalent to 30 min cycling at 75% Wattmax. Participants rinsed the mouth with 
6% glucose (CHO), 6% branched-chain amino acids (BCAA), or water (PLA) for 10 s at the 
start and after every 10 min during the steady-state exercise and cycle time trial. Treatment 
did not affect heart rate, ratings of perceived exertion, affect, arousal, plasma glucose and 
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lactate concentrations, and substrate oxidation during steady-state exercise and a cycle time 
trial. Furthermore, mouth rinsing BCAA or CHO did not affect plasma insulin or prolactin 
concentrations during steady-state exercise or a cycle time trial. Finally, mouth rinsing 
BCAA or CHO did not affect cycle time trial performance after steady-state exercise. In 
conclusion, mouth rinsing BCAA or CHO does not improve cycle time trial lasting 
approximately 30 min when performed after 30 min steady-state exercise. 
INTRODUCTION 
Attenuation of fatigue during training and competition is highly important for athletic 
endeavors. Two broad types of fatigue exist – central and peripheral. Peripheral fatigue is 
caused by factors outside the central nervous system, primarily in the muscle. Causes of 
peripheral fatigue include depletion of phosphocreatine, depletion of glycogen, accumulation 
of lactate, and malfunction of the neuromuscular transmission (3). Central fatigue refers to 
fatigue originating in the central nervous system and may involve: 1) an increase in key 
muscle compounds during physical activity, including H+, K+, bradykinin, phosphate, and 
prostaglandins that could transmit information from fatiguing muscle to the brain; 2) a 
decrease in the blood and brain glucose levels; and 3) an increase in the concentration of 
tryptophan (Trp) in the blood and hence the neurotransmitter 5-hydroxytryptamine (5-HT) in 
the brain (24). Plasma tryptophan is the amino acid precursor in the synthesis of 5-HT 
(serotonin) in the brain.  Tryptophan crosses the blood-brain barrier via the L-system, the 
Large Neutral Amino Acids (LNAA) transporter (6). Because branched-chain amino acids 
(leucine, isoleucine, valine; BCAA) are approximately 75% of the LNAA and are transported 
via the same transport system (17), they may compete with free tryptophan for brain uptake. 
Increasing the ratio of free tryptophan to BCAA (fTrp:BCAA) increases the amount of free 
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tryptophan that can cross the blood-brain barrier and is thought to increase the synthesis and 
release of 5-HT in the brain, causing central fatigue, which is associated with lethargy, 
fatigue, and decreased exercise performance (15). The Central Fatigue Theory posits that 
BCAA supplementation may decrease sensations of fatigue and lethargy and limit central 
fatigue by competing with free tryptophan for brain uptake, possibly improving exercise 
performance (7). Exercise decreases plasma BCAA and increases free tryptophan 
concentrations (14). Plasma BCAA concentrations increase in response to BCAA ingestion 
in a dose-dependent manner, but may return to baseline after one h of ingestion of less than 
one g BCAA. Branched-chain amino acids supplementation has been shown to decrease 
perceived exertion and increase endurance performance (7, 8) and reduce brain serotonin 
synthesis (19). Others have found that BCAA administration 70-90 min before short-term 
exercise does not impact physical performance (34, 35).  
Carbohydrate (CHO) ingestion improves exercise performance during prolonged 
exercise bouts (> 2 h) in which glycogen depletion may occur (20). However, the effects of 
CHO ingestion on exercise performance in shorter-term bouts are unclear. Carbohydrate 
ingestion before and during short-term and intense exercise sessions has been shown to delay 
fatigue and improve exercise performance (5, 13). However, results are equivocal (25). The 
mechanism underlying reported performance enhancement is not well understood. Because 
only 5 to 15g of exogenous CHO are oxidized in the first h of exercise, it is unlikely that 
improved exercise performance after CHO ingestion is due to enhanced CHO oxidation rates. 
There may be “nonmetabolic” or central mechanisms involved in increased exercise 
performance from CHO ingestion. Carter et al. (10) found that whereas intravenous glucose 
infusion (one g/min) resulted in higher circulating glucose, infusion did not improve exercise 
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performance. The group suggested that oral CHO feeding may exert its effects through a 
central mechanism, improving motor drive or motivations, mediated by receptors in the 
mouth or gastrointestinal (GI) tract. They found that simply rinsing the mouth with CHO, 
without swallowing, improved exercise performance (11). Because potential stimulation 
from GI tract receptors was eliminated, Carter and colleagues (11) suggested that non-sweet 
receptors may exist in the human mouth, capable of initiating a centrally mediated effect on 
exercise performance. Chambers et al. (12) suggested that unidentified oral receptors may 
exist that respond to the caloric property of carbohydrate, regardless of sweetness and the 
caloric content of solution mediates brain activation, which may in turn influence emotion,  
behavior, and potentially, exercise performance. Gant et al. (18) posited that unidentified 
class of receptors may exist that encode caloric information, influencing descending motor 
activity. The positive effects of mouth rinsing with CHO on exercise pervious have been 
supported by several subsequent studies involving fasted participants (12, 26, 27, 28), but not 
those in a fed state (4).  
Mouth rinsing with CHO has also been hypothesized to maintain blood insulin 
concentrations during exercise, which may enhance performance by stimulating glucose 
uptake into cells (11). The cephalic phase of insulin release (CPIR), a parasympathetic reflex 
caused by the sight, smell, and taste of food, has been observed in animals and humans. The 
β-cells of the pancreas secrete insulin before an increase in plasma glucose. Recent work has 
shown that sweet substances (caloric and non-caloric alike) presented to the mouth, but not 
ingested, stimulate the CPIR before a rise in plasma glucose concentrations (23, 33). 
This study will determine if mouth rinsing with other nutrients (BCAA) enhances 
exercise performance as measured by a cycle time trial. By using isocaloric solutions from 
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different nutrient sources (CHO and BCAA), this study will answer the question if the 
previously observed improvements in exercise performance from CHO mouth rinsing with 
were due to carbohydrates per se or the presentation of energy to the oral cavity. 
Furthermore, because BCAA are bitter and the CHO in the study is sweet, the study will 
determine if sweetness is a requisite property of mouth rinse solutions that improve exercise 
performance. Additionally, the effects of mouth rinsing with CHO or BCAA on the 
concentration of blood glucose during exercise, the steady-state metabolic response to 
exercise, and the pancreatic secretion of insulin during exercise are not known. Another 
major aim of the study is to determine the effects of rinsing the mouth with CHO or BCAA 
during exercise on markers of central fatigue. Plasma prolactin has been shown to be a 
surrogate index of brain serotonin levels (37) and will used as the blood marker of central 
fatigue.  
METHODS 
Experimental Approach to the Problem 
 All exercise tests were performed on an electronically braked cycle ergometer (Lode 
Excalibur, Groningen, The Netherlands). During the first visit to the laboratory, participants 
performed a graded exercise test to exhaustion to determine maximal aerobic capacity (VO2 
peak). Visit two was a familiarization session to familiarize participants with the steady-state 
metabolic response and cycle time trial procedures, subjective scales, and ensure they could 
complete the required exercise. On the experimental days, participants cycled for 30 min at a 
steady-state workload and were then instructed to perform a given amount of work as quickly 
as possible. During the experimental trials, participants were given either a 6% glucose 
solution (CHO), 6% branched-chain amino acids solution (BCAA; Leucine:Isoleucine:Valine 
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= 2:1:1), or water (PLA) to rinse around the mouth for ten s before and every ten min during 
exercise. Experimental trials were performed in a randomized, counter-balanced, single-
blind, placebo-controlled, within-subjects crossover design. Trials were separated by at least 
seven d.   
Subjects 
 Ten healthy, endurance-trained adult males (23.5 ± 3.8 y, 74.0 ± 9.0 kg, 180.5 ± 5.4 cm, 
57.9 ± 6.9 ml/kg/min VO2 peak) volunteered for the study. Training criteria included people 
currently engaged in endurance exercise for 30-60 min at least three times per week at 60-
80% heart rate reserve and able to exercise for approximately 60 min at 75% Wmax on a cycle 
ergometer. Participants were required to have a VO2 peak ≥ 50 ml/kg/min. People with a 
serious illness or disease such as hypertension, kidney or liver disease were excluded from 
the study. Participants were fully informed on the nature and possible risks of the 
experimental procedures before their written consents were obtained. The study was 
approved by the Iowa State University Human Subjects Institution Review Board. 
Procedures 
Maximal Aerobic Capacity 
 During the graded exercise test to exhaustion, participants cycled on a Lode Excalibur 
cycle ergometer. Power output increased 50 watts every two min until the participant reached 
volitional exhaustion. Ventilation, oxygen uptake (VO2), carbon dioxide production (VCO2), 
heart rate (HR; Polar, Finland), and ratings of perceived exertion (RPE; 9) were recorded 
continuously. Expired respiratory gases were collected and analyzed using a Max II 
Physiodyne metabolic cart (Physiodyne Instrument Corp, Quogue, NY) calibrated according 
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to manufacturer’s instructions. Seat position, handlebar height and orientation were recorded 
and replicated in each subsequent visit.  
Steady-State Metabolism and Time Trials   
 Participants entered the laboratory in the morning after an overnight fast, having 
abstained from caffeine, alcohol, tobacco, and exercise in the previous 24 h. Each participant 
performed the three experimental trials at the same time of day. On arrival to the laboratory, 
participants were weighed and fitted with a HR monitor (Polar, Finland). A polyethylene 
catheter was inserted into an antecubital vein for subsequent blood sampling. To prevent 
clotting, 0.9% sodium chloride injection (3 ml) was added to the vein. After a five min 
warm-up at 40% Wmax, participants cycled for 30 min at 65% Wmax to determine the effects 
of mouth rinsing with CHO and BCAA on steady-state metabolism and rate of oxygen 
consumption (VO2). Expired gases were collected the last two min of each ten min interval 
and analyzed for VO2 and the respiratory exchange ratio (RER). Participants then performed 
a cycle time trial in which they were instructed to perform a set amount of work in the 
shortest time possible. Total work performed was calculated according to a modification of 
the Jeukendrup et al. (21) equation: 
 Total amount of work = 0.75 x Wmax x 1,800  
where Wmax is the maximal workload capacity determined at visit one and 1,800 is the 
duration in s (equivalent to 30 min).  This test has been reported to be highly reproducible 
(21). The ergometer was set in the linear mode according to the formula W = L x (RPM)2 in 
which RPM is the pedaling rate and L is a linear factor. The linear mode was set so that 75% 
Wmax was obtained when the participants pedaled at their preferred cadence determined 
during the maximal aerobic capacity test. If the participants exercised at this pedaling rate, 
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they would have completed the time trial in exactly 30 min. The ergometer was connected to 
a computer that calculated and displayed the total amount of work performed. The only 
information the participant received during the time trial was the work performed and the 
percentage of work performed relative to the preset task. No encouragement was given to the 
participants and they were kept unaware of performance-related information, such as exercise 
time, heart rate, and cycling cadence. A fan was placed one meter behind the participant to 
provide cooling and air circulation during the trials. Heart rate was recorded continuously 
throughout the steady-state exercise and time trial using short-range telemetry (Polar, 
Finland). Ratings of perceived exertion (9) were recorded at the start and every ten min 
during the steady-state exercise and time trial. Expired gases were collected during the last 
two min of each ten min interval and analyzed for VO2 and respiratory exchange ratio (RER) 
during the time trial. During the time trial, no interaction between the participant and the 
investigators occurred except for subjective scales, blood draws, and mouth rinse 
administration. All people not involved in the study were excluded from the laboratory to 
prevent any external disruption. 
Oxidation of carbohydrate and fat was estimated based on the equations for moderate to high 
intensity exercise (50-75% VO2 max) by Jeukendrup & Wallis (22):  
 Carbohydrate oxidation (g/min) = 4.210 * VCO2 – 2.962 * VO2 – 0.40 * n 
 Fat oxidation (g/min) = 1.695 * VO2 – 1.701 * VCO2 – 1.77 * n 
where n represents nitrogen excretion in urine. Negligible protein oxidation was assumed.  
Mouth Rinse Protocol 
 Each participant was given a 25 ml bolus of either 6% glucose (CHO), 6% branched-
chain amino acids (BCAA), or water (PLA) at the start and every 7th min of each ten min 
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interval during the steady-state exercise and cycle time trial. Participants rinsed the fluid 
around the mouth for ten s before expectorating the fluid into a beaker. Each 25-ml bolus of 
solution was served in a plastic syringe (Kendal monoject). Participants were kept blind to 
the composition of the rinse treatments until the study was completed. Beverage 
administration was randomized via a random-number generator (SPSS v. 19).  
Evaluation of Treatments 
 Participants evaluated treatment solutions for bitterness and sweetness using 100 mm 
visual analog scales with anchors at 0 mm (Nil) and 100 mm (Extreme). Bitterness and 
sweetness was assessed before and after the steady-state exercise and time trial.  
Ratings of Perceived Exertion 
 Ratings of perceived exertion (9) is a scale that ranges from 6 (Very very light) to 20 
(Very very hard) and is used to determine the exercise exertion level of a participant. The 
RPE scale was administered at the start and every ten min during the 30 min steady-state 
exercise and time trial. 
Dietary and Physical Activity Procedures 
 To minimize intra-participant differences in starting liver and muscle glycogen 
concentrations, participants were instructed to record their diet for the three d before the first 
visit and to avoid exercise in the 24 h period before each visit. The three d diet record was 
copied and returned to the participant with instructions to follow the same diet before each 
subsequent visit. Diet compositions were analyzed using the Nutritionist Pro software 
program (Stafford, TX; Table 1). 
Blood Analyses 
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A blood sample (10 ml) was taken from the catheter inserted into an antecubital vein 
before exercise and every ten min during the steady-state exercise and the time trial. To 
prevent clotting, 0.9% sodium chloride (3 ml) was added to the vein after each blood draw. 
Samples were centrifuged for ten min at 2,200 rpm using an Allegra TM 6R centrifuge. 
Plasma was stored at -80°C until analysis. Plasma glucose and lactate concentrations were 
determined using a Yellow Springs Glucose/Lactate AutoAnalyzer (YSI Incorporated, 
Yellow Springs, OH, USA). Samples were analyzed in duplicate.  
Hormone Analysis 
 
Insulin 
All assays were performed in duplicate. Standard or sample (0.1 ml) was added to 12 
x 75 mm tubes. First antibody (0.1 ml; guinea pig antiserum vs. porcine insulin, 1:10,000) 
was added to each tube except blank tubes. Phosphate buffer with bovine serum albumin 
(0.04 M) was added to blank tubes (0.2 ml) and Z tubes (0.1 ml). Tubes were incubated 
overnight at 4°C. 125I-insulin (0.1 ml; ~20,000 counts per min (cpm)/0.1 ml) was added to all 
tubes. Tubes were incubated overnight at 4°C. Normal guinea pig plasma (0.1 ml; 1:80) and 
second antibody (0.1 ml; donkey anti-guinea pig IgG, 1:40) were added to each tube. Tubes 
were shaken and incubated at room temperature for 30 min. At least two tubes were counted 
during incubation for determination of total counts. Human plasma (0.1 ml) was added to 
each tube in the standard curve. Polyethylene glycol (1 ml; 12% in 0.85% NaCl) was added 
to each tube. Tubes were centrifuged at 3000 rpm for 30 min at 4°C. Supernatant was 
aspirated and tubes were counted for one min using a gamma counter. Standard curves for 
insulin concentration determination contained blank, Z, 0.78, 1.55, 3.125, 6.25, 12.5, 25, 50, 
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and 100 µU/ml. Reference standards (5, 20, and 50 µU/ml) were assayed to determined inter- 
and intra-assay variability. Radioactivity was measured using an automated gamma counter.  
Prolactin 
All assays were performed in duplicate. Standard or sample (0.1 ml) was added to 12 
x 75 mm tubes. Antibody (0.1 ml; rabbit anti-human prolactin, 1:50,000) was added to each 
tube except blank tubes. Assay buffer (0.1% BSA in 0.01 M PBS with 1 mg/ml sodium 
azide, pH 7.4) was added to blank tubes (0.2 ml) and Z tubes (0.1 ml). 125I-insulin (0.1 ml; 
~20,000 cpm/0.1 ml) was added to all tubes. Tubes were incubated overnight at 4 C. Normal 
rabbit plasma (0.1 ml; 1:80) and second antibody (0.1 ml; goat anti-rabbit IgG, 1:20) were 
added to each tube. Tubes were shaken and incubated at room temperature for 30 min. 
Standard curve tubes were counted during incubation for determination of total counts. 
Human plasma (0.1 ml) was added to each tube in the standard curve. Polyethylene glycol (1 
ml; 12% in 0.85% NaCl) was added to each tube. Tubes were centrifuged at 3000 rpm for 30 
min at 4°C. Supernatant was aspirated and tubes were counted for one min using a gamma 
counter. Standard curves for prolactin concentration contained blank, Z, 0.3125, 0.625. 1.25, 
2.5, 5, 10, 20, and 40 ng/ml. The reference standard (16 ng/ml) was assayed to determine 
inter- and intra-assay variability. 
Iodination and purification of human prolactin 
A Sephadex G75 column was made. A 10-ml pipet was packed with Sephadex G75 
beads (1g in 20 ml of 0.01 M PBS with 1 mg/ml BSA) in room temperature. A mark was 
made on the pipet 20 cm from the bottom of the column. The pipet was filled with buffer to 
the 20 cm mark and beads were dropped into the column. After beads were settled in the 
bottom of the column, a valve was opened allowing buffer to flow out of the pipet. 
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Additional beads were added until 20 cm were packed into the column. Buffer (3-5 ml) was 
added on top of the beads. The column was stored at 4°C overnight.  
The Sephadex column was removed from refrigeration one h before iodination to 
bring the column to room temperature.  In a 12 x 75 mm prolactin tube (5µg/5µl), 35 µl 0.3 
M PO4, 1 mCi Na 125I, and 10 µl chloramine T were added at room temperature. After two 
min, a small aliquot (~1 µl) was removed and added to a mixture of 1 ml TCA (10%) and 1 
ml 2.5% BSA in 0.01 M PO4. The tube was centrifuged and pellet and supernatant were 
counted. Na metabisulfite (10 µl) was added to stop iodination. The mixture was transferred 
to the Sephadex G75 column. Fractions (0.3 ml; n=40) were collected and 5 µl of each 
fraction were counted for 30 s. The first peak detected was free 125I and second peak detected 
was 125I-prolactin.   
Statistical Analysis 
Data were analyzed using SPSS 19.0 statistical analysis software (SPSS Inc., Chicago, IL, 
USA). Missing data were estimated using the series mean method for replacing missing values. Data 
were screened for normality of distribution (Kolmogorov-Smirnov test) and equality of variances 
(Levene’s test for equality of variances). When appropriate, non-normal data were transformed into 
ranked cases for all trials combined. Ranks were then separated by trial for analysis. Data were 
analyzed using a series of two-factor analyses of variance (ANOVA) with repeated measures 
(treatment x time). Greenhouse-Geisser epsilon corrections were used when the assumption of 
sphericity was violated. Partial η2 was used to determine effect size (ES). Post hoc or pairwise mean 
differences were examined after Bonferroni adjustments. All levels of significance were set at P< 
0.05. All data are presented as means ± standard deviations. 
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RESULTS 
Treatment evaluation 
Participants evaluated BCAA as more bitter than CHO or PLA during the steady-state 
trial (78 ± 14, 6 ± 7, 11 ± 19 mm, respectively; P < 0.001, Figure 1A) and the time trial (81 ± 
14, 5 ± 6, and 12 ± 21 mm, respectively, P < 0.001, Figure 1B). Conversely, participants 
evaluated CHO as sweeter than BCAA or PLA during the steady-state trial (49 ± 21, 6 ± 5, 
and 6 ± 6 mm, respectively, P < 0.001, Figure 2A) and the time trial (51 ± 17, 7 ± 6, and 7 ± 
6 mm, respectively, P < 0.001, Figure 2B).   
Substrate Oxidation 
Carbohydrate oxidation 
The main effect of time for the carbohydrate oxidation rate during the steady-state 
trial was significant (P < 0.001, Figure 3A). The carbohydrate oxidation rate decreased 
during the steady-state trial (2.83 ± 0.48, 2.69 ± 0.49, and 2.55 ± 0.56 g/min for min 10, 20, 
and 30, respectively). The main treatment effect and the treatment x time interaction were not 
significant.  
The main treatment and time effects and the treatment x time interaction for the 
carbohydrate oxidation rate during the time trial were not significant (Figure 3B).  
Fat oxidation 
The main effect of time for the fat oxidation rate during the steady-state trial was 
significant (P < 0.001, Figure 4A). The fat oxidation rate increased during the steady-state 
trial (0.43 ± 0.21, 0.54 ± 0.21, and 0.61 ± 0.22 g/min for min 10, 20, and 30, respectively). 
The main treatment effect and the treatment x time interaction were not significant.    
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The main effect of time for the fat oxidation rate during the time trial was significant 
(P = 0.002, Figure 4B). The fat oxidation rate during the time trial was greater at 30 min 
(0.68 ± 0.22 g/min) than 10 or 20 min (0.58 ± 0.22and 0.63 ± 0.20 g/min, respectively). The 
main treatment effect and the treatment x time interaction were not significant. 
Heart rate 
The main effect of time for heart rate during the steady-state trial was significant (P < 
0.001, Table 2). The main treatment effect and the treatment x time interaction were not 
significant.   
The main effect of time for heart rate during the time trial was significant (P < 0.001, 
Table 3). The main treatment effect and the treatment x time interaction were not significant. 
Ratings of perceived exertion 
The main effect of time for ratings of perceived exertion was significant (P < 0.001, 
Table 2). The main treatment effect and the treatment x time interaction were not significant. 
The main effect of time for ratings of perceived exertion during the time trial was 
significant (P < 0.001, Table 3). The main treatment effect and the treatment x time 
interaction were not significant. 
Insulin 
The main effect of time for insulin during the steady-state trial was significant (P < 
0.001, Figure 5A). Insulin concentrations were higher pre steady-state (7 ± 8 µU/ml) than at 
min 10 (6 ± 8 µU/ml) during the steady-state trial, with resting values (6 ± 8 µU/ml) being 
intermediate. Insulin concentrations were lower at min 20 and 30 (5 ± 6 and 4 ± 5 µU/ml, 
respectively) than resting concentrations, with min 10 being intermediate. The main 
treatment effect and the treatment x time interaction were not significant. 
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The main effect of time for insulin during the time trial was significant (P < 0.001, 
Figure 5B). Insulin was higher pre time trial than min 10 (7 ± 8 and 3 ± 4 µU/ml, 
respectively), which in turn was higher than min 20 and 30 and post time trial (3 ± 4, 3 ± 4, 
and 2 ± 4 µU/ml, respectively). The main treatment effect and the treatment x time 
interaction were not significant. 
Prolactin 
Prolactin concentrations were not affected by treatment or time during the steady-
state trial (Figure 6A) or the time trial (Figure 6B). 
Lactate 
The main effect of time for lactate during the steady-state trial was significant (P < 
0.001, Figure 7A). Lactate decreased from rest to pre steady-state (2.5 ± 1.5 and 1.4 ± 0.4 
mmol/L, respectively). Lactate increased during the steady-state trial until 20 min, which did 
not differ from 30 min (3.8 ± 1.7, 4.3 ± 2.1, and 4.5 ± 2.3 mmol/L for min 10, 20, and 30, 
respectively). The main treatment effect and the treatment x time interaction were not 
significant. 
The main effect of time for lactate during the time trial tended to be significant (P = 
0.072, Figure 7B). The main treatment effect and the treatment x time interaction were not 
significant. 
Glucose 
The main effect of time for glucose during the steady-state trial was significant (P = 
0.040, Figure 8A). Glucose was higher pre steady-state than min 10 (4.9 ± 0.5 and 4.8 ± 0.5 
mmol/L, respectively), with all other time points being intermediate. The main treatment 
effect and the treatment x time interaction were not significant. 
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The main effect of time for glucose during the time trial was significant (P < 0.001, 
Figure 8B). Glucose was higher pre time trial (5.5 ± 0.6 mmol/L) than all other time points. 
Glucose at min 20 was lower than glucose at min 30, with min 10 being intermediate (4.6 ± 
0.7, 4.7 ± 0.7, and 4.5 ± 0.6 mmol/L, respectively). Glucose post time trial (5.0 ± 0.8 
mmol/L) was higher than min 10, 20, and 30. The main treatment effect and the treatment x 
time interaction were not significant. 
Time trial performance 
The main treatment effect for cycle time trial performance was not significant (Figure 
9). Time required to complete the cycle time trial was 35.9 ± 3.8, 36.0 ± 3.3, and 35.2 ± 2.8 
min for BCAA, CHO, and PLA, respectively.  
DISCUSSION 
The main findings of this study are that mouth rinsing with BCAA or CHO does not 
affect heart rate, ratings of perceived exertion, plasma insulin, prolactin, glucose, and lactate 
concentrations, and substrate oxidation during steady-state exercise. Additionally, mouth 
rinsing with BCAA or CHO does not affect cycle time trial performance after steady-state 
exercise.  
We chose BCAA as a rinse treatment because it has been postulated that presentation 
of energy to the mouth, regardless of solution sweetness, stimulates reward centers of the 
brain and may increase motor output and drive (12). Furthermore, ingestion of BCAA has 
been observed by some (7, 8) but not all (34, 35) to enhance exercise performance. We found 
that mouth rinsing with BCAA had no effect on exercise performance. Several studies have 
demonstrated that mouth rinsing with CHO during exercise improves exercise performance 
(11, 12, 26,  27, 28). However, others have observed no benefit of mouth rinsing with CHO 
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without ingestion (29) or when participants are in a fed state (4). The present study 
corroborates the findings of Rollo et al. (29) that mouth rinsing with CHO does not enhance 
exercise performance. Rollo et al. (29) suggested they may have failed to observe a benefit 
from mouth rinsing with a carbohydrate-electrolyte (CE) solution because participants mouth 
rinsed and ingested placebo and mouth rinsed and expectorated the CE. These authors 
suggested that ingestion of a fluid per se may have a beneficial effect on performance. In the 
present study, no treatments were ingested; therefore direct comparison to the study by Rollo 
et al. (29) is challenging. 
There is no clear explanation why others have observed an increase in exercise 
performance in response to mouth rinsing with CHO solutions. There may be 
“nonmetabolic” or central mechanisms involved in increased exercise performance involving 
CHO ingestion. Carter and colleagues (11) observed improvements in exercise performance 
when participants mouth rinsed with maltodextrin and suggested that non-sweet receptors 
may exist in the human mouth capable of initiating a centrally mediated effect on exercise 
performance. Chambers et al. (12) corroborated the findings of Carter et al. (11) and found 
that mouth rinsing with sweet (glucose) and non-sweet solutions (maltodextrin) may 
enhanced exercise performance in bouts lasting ~ one h. Pottier et al. (26) found that mouth 
rinsing with a commercially available CE solution resulted in less time to complete a one h 
time trial than rinsing with placebo, whereas ingestion of CE did not. Pottier et al. (26) 
suggested that afferent signals from CHO receptors in the oral cavity may attenuate afferent 
signals from the muscle to the brain. Gant et al. (18) found that ingestion of CHO 
immediately improved performance by increasing corticomotor excitability and maximal 
voluntary force production. Additionally, Gant et al. (18) posited that because the CHO in 
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their study was non-sweet maltodextrin, signal transduction by receptors sensitive to energy 
density, not sweetness may occur. The authors hypothesized that separate binding sites on the 
sweet receptor may exist for sweetness and energy density or unidentified class of receptors 
may exist that encode caloric information. The results of the current study do not support the 
previous findings that rinsing the mouth non-sweet or sweet solutions improve exercise 
performance.  
In the study by Beelen et al. (4), mouth rinsing with CHO did not affect time trial 
performance when participants were in a fed state. Because RPE were unaffected by 
carbohydrate mouth rinse, the authors refute the hypothesis that rinsing with the oral cavity 
with carbohydrate stimulates pleasure and reward centers of the brain. Beelen et al. (4) 
suggested that putative glucose receptors in the mouth may be more important or influential 
during states of glycogen depletion and less important during states of adequate glycogen 
stores, hence the lack of effect of benefit of mouth rinsing with CHO in their study. In the 
present study, participants exercised for approximately one h. Whereas muscle glycogen 
content was not measured, it is likely that adequate stores were available for use; therefore, it 
is possible that ergogenic effects of mouth rinsing with BCAA or CHO were not observed 
due to adequate muscle glycogen content. Future research on the effects of rinsing the mouth 
with energy-containing solutions during long-term exercise in which glycogen depletion 
occurs is therefore warranted.   
The cephalic phase of insulin release (CPIR) has been observed in animals and 
humans. The β-cells of the pancreas secrete insulin before an increase in plasma glucose. The 
CPIR is a parasympathetic reflex caused by the sight, smell, and taste of food and is of 
cephalic origin. Whereas the secretion of insulin during the CPIR is relatively small, it plays 
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an important role in preparing the body for caloric consumption by preventing large increases 
in blood glucose after eating (2). Taste qualities of foodstuffs may influence the CPIR. 
Placing sour, salty, bitter, and umami treatments on the tongues of rats for 45 s did not affect 
plasma glucose or insulin concentrations (33). However, Tonosaki et al. (33) found that 
sweet, caloric-containing CHO stimulated the CPIR in rats before an increase in plasma 
glucose; sweet, non-caloric substances stimulated the CPIR without affecting plasma glucose 
concentrations and non-sweet, caloric-containing substances did not stimulate the CPIR or 
affect plasma glucose concentrations. Just et al. (23) observed a similar effect in humans. 
They found that whereas intra-oral stimulation with sour, salty, bitter, and umami taste 
qualities did not elicit the CPIR, intra-oral stimulation of both sucrose and saccharin (sweet 
substances) resulted in a transient increase in plasma insulin five min after stimulation. It has 
been hypothesized that mouth rinsing with CHO during exercise may maintain insulin levels, 
thereby enhancing glucose availability and subsequently CHO oxidation rates, enhancing 
exercise performance exercise (11). To our knowledge, the present study is the first to 
investigate the effects of mouth rinsing with CHO or BCAA on insulin secretion during 
exercise. Whereas plasma insulin concentrations decreased during exercise, we found that 
mouth rinsing with a bitter (BCAA) or sweet (CHO) solution had no effect on plasma insulin 
concentrations during steady-state exercise or a cycle time trial. Our findings corroborate 
those of others (23, 33) that bitter solutions (BCAA) do not stimulate the CPIR. However, it 
should be noted that in the present study, plasma insulin concentrations were measured 
during exercise, whereas the studies by Tonosaki et al. (33) and Just et al. (23) did not 
involve exercise. Rollo et al. (27), found that plasma insulin concentrations did not change 
during 60 min of rest and were unaffected by mouth rinsing with a 6.4% CE solution. Plasma 
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insulin concentrations typically rise within two min, peak at four min, and return to baseline 
within ten min after oral stimulation (30, 31, 32). We obtained blood samples approximately 
three min after mouth rinsing with BCAA or CHO. Therefore, it is possible that insulin 
secretion was stimulated by mouth rinsing with BCAA or CHO, but we did not observe the 
secretion due to sampling timing. However, any such effect of mouth rinsing with on insulin 
secretion did not influence exercise performance or substrate oxidation in the present study.  
In the present study, plasma insulin and glucose concentrations and the CHO and fat 
oxidation rates were not influenced by mouth rinsing with BCAA or CHO. Our findings 
corroborate those of Rollo et al. (29), who found that mouth rinsing with a CE solution does 
not affect the CHO oxidation rate during a time trial, whereas rinsing with and ingesting CE 
does increase the CHO oxidation rate during exercise. Pottier et al. (26) found no difference 
in blood glucose between mouth rinsing with a CE solution and placebo. In the present study, 
blood glucose concentrations during steady-state exercise or a cycle time trial were not 
affected by rinsing with CHO, BCAA, or PLA. Our findings corroborate those of Rollo et al., 
(2010), who found no changes in plasma glucose concentrations from pre- to post-exercise 
when participants mouth rinsed with CHO. Therefore, the improvement in exercise 
performance observed in other studies likely does not involve greater availability of blood 
glucose for oxidation.  
The effects of mouth rinsing with CHO on ratings of perceived exertion are 
equivocal. Whitham and McKinney (36) found that mouth rinsing with a carbohydrate 
solution did not alter RPE during a 45 min running time trial. Rollo et al. (29) also observed 
no effect of mouth rinsing with CHO on RPE. Our results corroborate these findings that 
mouth rinsing with BCAA or CHO does not affect RPE during steady-state exercise or a time 
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trial. However, others have suggested that mouth rinsing with CHO may lower perception of 
exertion at a given exercise intensity (11, 26, 28, 12). Pottier et al. (26) hypothesized that 
presentation of CHO to the mouth may attenuate afferent signals of fatigue from the 
contracting muscle, allowing participants to produce more power at a given level of 
perceived exertion. Rollo et al. (28) suggested that carbohydrate presentation to the mouth 
may result in a “feel good” effect. Rollo et al. (28) speculated that the brain may monitor the 
physiological integrity of muscle or whole-body carbohydrate stores. Presentation of CHO to 
the mouth may relay signals to the brain of an incoming energy source. This promise of 
energy may increase generate a transient increase in power output or exercise performance 
and heighten pleasure. However, when the brain receives feedback that no energy source 
arrived, exercise behavior and affect or mood state may be adjusted accordingly. Therefore, it 
may be important to rinse the mouth at given intervals. The time-course of such responses 
has yet to be elucidated.  
Interestingly, prolactin concentrations did not change from resting levels during 
exercise, which conflicts with other findings (1, 38). However, prolactin concentrations do 
not increase during exercise at intensities corresponding to a VO2 of less than 40 ml/kg/min 
(38), or below the ventilatory threshold (16). Since theVO2 was ~ 40 ml/kg/min during the 
time trial in the present study, the exercise intensity may have not been stressful enough to 
stimulate prolactin secretion. However, because prolactin concentrations did not increase 
during either the steady-state exercise or the time trial, it is possible that serotonin activity 
was attenuated during exercise in the present study from mouth rinsing with fluids per se. If 
serotonin activity was attenuated during exercise by mouth rinsing with BCAA or CHO, 
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these neuroendocrine responses did not influence motor output as measured by cycle time 
trial performance. 
In conclusion, mouth rinsing with BCAA or CHO does not affect cycle time trial 
performance after steady-state exercise. Mouth rinsing with BCAA or CHO does not affect 
heart rate, ratings of perceived exertion, plasma glucose and lactate concentrations, and 
substrate oxidation during steady-state exercise and a cycle time trial. Markers of central 
fatigue (plasma prolactin concentrations) were also not affected by mouth rinsing with 
BCAA or CHO. Mouth rinsing with BCAA or CHO did not affect plasma insulin 
concentrations during steady-state exercise or a cycle time trial. 
PRACTICAL APPLICATIONS 
The findings of this study suggest that mouth rinsing with carbohydrates or branched-
chain amino acids during moderate-intensity cycling does not affect exercise performance. A 
coach seeking nutritional means of improving sport and exercise performance may suggest 
mouth rinsing and ingesting carbohydrates during training or competition. However, this 
study provides no evidence that only mouth rinsing carbohydrates improves exercise 
performance.  
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Tables and Figures 
 
Table 1. Analysis of three d diet records. Values are mean ± SD.  
 
 Day 1 Day 2 Day 3 
Energy, kcal 2866 ± 1158 2854 ± 954 2245 ± 822 
Carbohydrate, g 340 ± 163   341 ± 143   271 ± 125 
Protein, g     131 ± 54 130 ± 48 102 ± 47 
Fat, g     109 ± 58 110 ± 48   88 ± 35 
 
Table 2. Heart rate (HR) and ratings of perceived exertion (RPE) during steady-state 
exercise. Values are mean ± SD. Time points within a measure with different superscripts are 
different (P < 0.05). 
 
 
Steady-State (Time) 
Measure/Trial Rest Pre 10 20 30 
Heart rate, 
bts/min       
   BCAA   74 ± 16a 77 ± 12a 151 ± 10b 157 ± 17c 161 ± 18c 
   CHO 73 ± 8a 81 ± 15a 155 ± 15b 160 ± 14c 162 ± 16c 
   PLA   74 ± 14a 78 ± 14a 153 ± 20b 157 ± 18c 155 ± 15c 
RPE       
   BCAA   6 ± 0a 7 ± 1a 13 ± 2b 14 ± 2c 15 ± 2d 
   CHO   6 ± 0a 6 ± 1a 12 ± 2b 14 ± 2c 14 ± 1d 
   PLA   6 ± 0a 6 ± 1a 11 ± 4b 14 ± 2c 14 ± 3d 
 
     
 
Table 3. Effects of mouth rinsing with BCAA and CHO on heart rate (HR) and ratings of 
perceived exertion (RPE) during cycle time trial. Time points within a measure with different 
superscripts are different (P< 0.05). 
 
 
Time Trial (Time) 
Measure/Trial Pre 10 20 30 Post 
Heart Rate, 
bts/min       
   BCAA 105 ± 13a 160 ± 19b 164 ± 16b 163 ± 14b 170 ± 16c 
   CHO 107 ± 12a 163 ± 14b 164 ± 15b 167 ± 13b 170 ± 16c 
   PLA 106 ± 13a 163 ± 18b 163 ± 18b 164 ± 18b 168 ± 23c 
RPE      
   BCAA   7 ± 2a 14 ± 3b 15 ± 2c 16 ± 2d 16 ± 2d 
   CHO   7 ± 2a 14 ± 1b 15 ± 2c 15 ± 2d 15 ± 4d 
   PLA   7 ± 1a 14 ± 2b 15 ± 2c 15 ± 2d 16 ± 2d 
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Figure 1A. Evaluation of BCAA, CHO, and PLA bitterness pre- and post-steady-state 
exercise. Values are mean + SD. * BCAA more bitter than CHO or PLA (P < 0.001).  
 
 
 
 
Figure 1B. Evaluation of BCAA, CHO, and PLA bitterness pre- and post-cycle time trial. 
Values are mean + SD. * BCAA more bitter CHO or PLA (P < 0.001). 
* * 
* * 
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Figure 2A. Evaluation of BCAA, CHO, and PLA sweetness pre- and post-steady-state 
exercise. Values are mean + SD. * CHO sweeter than BCAA or PLA (P < 0.001). 
 
 
 
 
Figure 2B. Evaluation of BCAA, CHO, and PLA sweetness pre- and post-cycle time trial. 
Values are mean + SD. * CHO sweeter than BCAA or PLA (P < 0.001). + Solutions 
evaluated as sweeter post-time trial than pre-time trial (P < 0.05). 
 * * 
* 
+ 
* 
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Figure 3A. The CHO oxidation rate in response to mouth rinsing with BCAA, CHO, and 
PLA during steady-state exercise. Values are means ± SD. Time points with different 
superscripts are different (P < 0.05). 
 
 
 
 
Figure 3B. The CHO oxidation rate in response to mouth rinsing with BCAA, CHO, and 
PLA during the cycle time trial. Values are means ± SD.  
c b a 
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Figure 4A. The fat oxidation rate in response to mouth rinsing with BCAA, CHO, and PLA 
during steady-state exercise. Values are means ± SD. Time points with different superscripts 
are different (P < 0.05). 
 
 
 
Figure 4B. The fat oxidation rate in response to mouth rinsing with BCAA, CHO, and PLA 
during the cycle time trial. Values are means ± SD. Time points with different superscripts 
are different (P < 0.05). 
a 
b 
c 
a a 
b 
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Figure 5A. Plasma insulin response to mouth rinsing with BCAA, CHO, and PLA during 
steady-state exercise. Values are means + SD. Time points with different superscripts are 
different (P < 0.05). 
 
 
 
 
Figure 5B. Plasma insulin response to mouth rinsing with BCAA, CHO, and PLA during the 
cycle time trial. Values are means + SD. Time points with different superscripts are different 
(P < 0.05).  
a 
ab bc 
c 
c 
a 
b c c 
c 
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Figure 6A. Plasma prolactin response to mouth rinsing with BCAA, CHO, and PLA during 
steady-state exercise. Values are means ± SD.  
 
 
 
 
Figure 6B. Plasma prolactin response to mouth rinsing with BCAA, CHO, and PLA during 
the cycle time trial. Values are means ± SD.  
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Figure 7A. Plasma lactate response to mouth rinsing with BCAA, CHO, and PLA during 
steady-state exercise. Values are means ± SD. Time points with different superscripts are 
different (P < 0.05). 
 
 
 
 
 
Figure 7B. Plasma lactate response to mouth rinsing with BCAA, CHO, and PLA during the 
cycle time trial. Values are means ± SD. 
a 
b 
c 
d 
d 
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Figure 8A. Plasma glucose response to mouth rinsing with BCAA, CHO, and PLA during 
steady-state exercise. Values are means ± SD. Time points with different superscripts are 
different (P < 0.05). 
 
Figure 8B. Plasma glucose response to mouth rinsing with BCAA, CHO, and PLA during the 
cycle time trial. Values are means ± SD. Time points with different superscripts are different 
(P < 0.05). 
a b ab 
ab ab 
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Figure 9. Time to complete the cycle time trial when mouth rinsing with BCAA, CHO, and 
PLA. Values are means ± SD.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
104 
 
CHAPTER 4. GENERAL CONCLUSIONS 
The results of this dissertation research suggest that mouth rinsing with branched-
chain amino acids and carbohydrates does not influence exercise performance in cycle time 
trials lasting approximately 30 min when performed after 30 min of steady-state exercise. 
Whereas there are several previous studies showing that mouth rinsing with carbohydrates 
improves performance, coaches and athletes should be aware that mouth rinsing with 
carbohydrates and branched-chain amino acids may not improve exercise or sport 
performance. However, one cannot rule out the possibility of a “placebo effect.” Athletes 
who have read or heard that mouth rinsing with carbohydrates improves exercise 
performance may realize positive performance benefits from mouth rinsing with 
carbohydrates simply because they think expect a benefit from mouth rinsing carbohydrates. 
This placebo effect has been demonstrated in a classic study of anabolic steroids (Ariel & 
Saville, 1972).  
This dissertation research also shows that mouth rinsing with carbohydrates and 
branched-chain amino acids does not influence substrate oxidation or plasma glucose or 
insulin concentrations during steady-state exercise or during a cycle time trial. Therefore, 
exercise metabolism is not affected by mouth rinsing with carbohydrates or branched-chain 
amino acids. Additionally, mouth rinsing with sweet (carbohydrates) and non-sweet or bitter 
(branched-chain amino acids) solutions does not influence insulin secretion during exercise. 
Any potential ergogenic effect of mouth rinsing with carbohydrates is therefore likely due to 
nonmetabolic or central factors. We also conclude from this research that mouth rinsing with 
carbohydrates and branched-chain amino acids does not affect central fatigue, as measured 
by the surrogate index of serotonin – plasma prolactin concentrations. Finally, mouth rinsing 
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with carbohydrates and branched-chain amino acids does not affect the subjective exercise 
experience during 30 min steady-state exercise or a cycle time trial, as measured by ratings of 
perceived exertion, feeling scale, and felt activation scale.  
There remains a need for additional research in the area of mouth rinsing with energy-
containing solutions on exercise performance. To date, the effects of mouth rinsing with 
carbohydrates on anaerobic performance are not known. Additionally, the effects of mouth 
rinsing with carbohydrates on longer duration exercise (lasting more than one h) have yet to 
be determined. Whereas ingestion of branched-chain amino acids may improve aerobic 
exercise performance, we have demonstrated that mouth rinsing with branched-chain amino 
acids does not influence aerobic exercise performance. Recent work has shown that mouth 
rinsing and ingesting carbohydrates increased distance ran in one h versus only mouth rinsing 
carbohydrates (Rollo et al., 2011). A study designed to determine the effects of mouth rinsing 
and ingesting branched-chain amino acids is therefore warranted.   
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ABSTRACT 
Previous research suggests that branched-chain amino acids (BCAA) supplementation 
may attenuate perception of muscle soreness after exercise. The purpose of this study was to 
determine the effects of acute BCAA supplementation before exercise on muscle function, 
appraisal of muscle soreness, and plasma creatine phosphokinase (CPK) and lactate 
dehydrogenase (LDH) activities after eccentric exercise. Forty-five middle-aged people (25 
women, 20 men; 48 ± 6 y) volunteered for this randomized double-blind study. Participants 
ingested either 8 g BCAA (Ile:Leu:Val = 1:2:1) or placebo (PL) and immediately performed 
6 sets of 10 repetitions of eccentric knee extensions and flexions at 120% of peak concentric 
torque. A 5-repetition isokinetic muscle function test of knee extensions and flexions was 
performed before and 1 and 2 days after eccentric exercise. A 4-wk washout period separated 
the two trials. Sub-group analysis revealed the change in mean extension power during the 5-
repetition test from Day 1 to Day 2 was different for BCAA and PL in women (P = 0.02, 
Effect size (ES) = 0.67). The change in mean flexion power from Day 1 to Day 2 was also 
different for BCAA and PL in women (P = 0.03, ES = 0.65). Ratings of muscle soreness and 
plasma CPK and LDH activities were mild and not different between BCAA and PL. These 
results suggest that a single dose of BCAA eliminates the loss in muscle power output 
observed in women after exercise that produces mild muscle damage. BCAA 
supplementation did not reduce plasma markers of muscle damage. 
 
 
KEY WORDS:  ergogenic aids, sport drinks, muscle damage, branched-chain amino acids  
108 
 
INTRODUCTION 
 Branched-chain amino acids have been reported to stimulate maintenance of immune 
function after endurance exercise (3), promote faster buffer capacity adaptation to training 
(36), increase exercise time to exhaustion (24), increase exercise time to exhaustion in the 
heat (22), increase oxygen-carrying capacity in the blood (26), improve cognition after an 
endurance race (14), and increase voluntary physical activity in rats (32). Additionally, 
branched-chain amino acids, particularly leucine, play an important role in protein 
metabolism. Leucine promotes protein synthesis and inhibits protein degradation, thereby 
potentially increasing protein accretion (5). Furthermore, BCAA supplementation before 
exercise may attenuate endogenous muscle protein catabolism (20).  
Exercise causes damage to the skeletal muscle fibers, which lasts for several days 
(12). Damage to the sarcolemma results in marked elevations in plasma levels of muscle 
enzymes such as creatine phosphokinase (CPK; 18). Chronic BCAA supplementation may 
suppress the rise in serum creatine phosphokinase activity for several days after exercise (8). 
Acute ingestion of BCAA before squat exercise decreased subjective evaluation of muscle 
soreness for three days after exercise (31). Additionally, BCAA ingestion before and at 60 
minutes of a 90-minute cycling bout decreased serum CPK levels 4-, 24-, and 48-hours after 
exercise, and serum lactate dehydrogenase (LDH) levels 4 hours after exercise, compared to 
placebo (11). While the exact mechanism has yet to be elucidated, BCAA supplementation 
may attenuate endogenous muscle protein catabolism, muscle fiber membranes may be 
enhanced, thereby decreasing membrane leakiness. 
 Delayed-onset muscle soreness (DOMS), which typically occurs one to five days 
after exercise and accompanies muscle membrane damage, can adversely affect exercise or 
109 
 
sport performance. For example, concentric elbow extension torque decreased after eccentric 
exercise and was lowest one day after eccentric exercise (33). The ability of muscles to 
generate force can be attenuated, thereby negatively influencing performance in the short-
term (2).  
The mechanism responsible for the potential prophylactic effect of branched-chain 
amino acids on muscle damage is currently unknown. However, the attenuation of exercise-
induced protein degradation and stimulation of protein synthesis by BCAA supplementation 
may be involved (30). Branched-chain amino acids activate enzymes in the signaling 
pathway in protein synthesis after exercise particularly stimulating phosphorylation of p70S6k 
protein at Ser424/Thr421 and phosphorylation of protein p70S6k at Thr389. This signaling 
cascade may enhance protein synthesis during skeletal muscle recovery after resistance 
exercise (4, 13). A single BCAA supplement (2 g BCAA plus 0.5 g arginine) at minute ten of 
the first of three 20-minute cycling exercise bouts at 50% maximal work intensity 
significantly reduced exercise-induced skeletal muscle proteolysis, measured by 
phenylalanine release from the working leg during the third exercise bout (21).  
The effects of an acute BCAA supplementation on muscle function, plasma enzyme 
activities, and subjective evaluation of muscle soreness are not fully understood. Therefore, 
the purpose of the present study was to determine the effects of an acute BCAA 
supplementation before exercise on subjective appraisal of muscle soreness, plasma creatine 
phosphokinase and lactate dehydrogenase activities, muscle torque and power, and ratings of 
perceived exertion.         
METHODS 
Experimental Approach to the Problem 
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To investigate the effects of acute BCAA supplementation before exercise on muscle 
function, appraisal of muscle soreness, and plasma creatine phosphokinase and lactate 
dehydrogenase  activities after eccentric exercise, forty-five middle-aged people completed 
this randomized, double-blind study. Participants ingested either 8 g BCAA (Ile:Leu:Val = 
1:2:1) or placebo and immediately performed 6 sets of 10 repetitions of eccentric knee 
extensions and flexions at 120% of peak concentric torque. A 5-repetition isokinetic muscle 
function test of knee extensions and flexions was performed before and 1 and 2 days after 
eccentric exercise. A 4-week washout period separated the two trials. 
Subjects 
An email was sent to all faculty and staff at Iowa State University requesting men and 
women volunteers age 40-60 years for an exercise and nutrition study. Potential participants 
were screened for height, mass, body composition, blood pressure, and heart rate prior to 
enrollment in the study. Body composition was estimated by bioelectrical impedance analysis 
using a Quantum X Bioelectrical Body Composition Analyzer (RJL Systems; Clinton Twp., 
MI). Potential participants also completed a short training session on a dynamometer exercise 
machine (BiodexTM, Shirley, NY) performing knee extensions and flexions. Persons not 
meeting any exclusion criteria (highly endurance or resistance trained, ingesting protein 
supplements or heart patients) were included in the study. Participant characteristics are 
provided in Table 1. Baseline plasma creatine phosphokinase and lactate dehydrogenase 
values were higher in men than women (P ≤ 0.05). There was no difference between men and 
women in age or body mass index (BMI). The study was approved by the Iowa State 
University Human Subjects Institution Review Board. Participants gave their informed 
consent before inclusion in the study. 
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Procedures 
Participants enrolled in this study completed two three-day trials in a randomized, 
double-blind cross-over design separated by a washout period of at least four weeks. Prior to 
each three-day trial, participants were asked to refrain from strenuous exercise for three days 
before the trial until completion of the trial. Participants entered the lab at 06:00 or 07:30 
hours after an overnight fast. Body mass, heart rate, and blood pressure were measured. 
Subjective muscle soreness of the right leg (0-9; 0, no soreness; 9, unbearable soreness; 17) 
was assessed. A small blood sample was taken from an antecubital vein using a sterile 21 
gauge Butterfly® needle. To prevent clotting, 0.9% sodium chloride injection (3 ml) was 
added to the vein. After five minutes, blood (5 ml) was collected in 16 x 100 mm Monoject* 
blood collection tubes containing 15% EDTA (K3) liquid. Samples were centrifuged for ten 
minutes at 2200 rpm using an Allegra TM 6R centrifuge. Red blood cells were separated from 
plasma and discarded. Plasma was stored in Fisherbrand® 12 x 75 mm polypropylene culture 
test tubes. Plasma for CPK analysis was frozen at -80°C until analysis.  
Participants were fed a small meal (200 g jelly-like food; 100 kcal) (Otsuka 
Pharmaceutical) to break fasts. Thirty minutes post-ingestion, participants performed a five-
repetition isokinetic strength and power test of right leg concentric knee extensions and 
flexions at 1.05 rad/s (60°/s) using a dynamometer (BiodexTM, Shirley, NY). Peak torque and 
average power were recorded. Immediately after the strength test, participants were given a 
500 ml drink containing either 8 g branched-chain amino acids (BCAA) 
(Isoleucine:Leucine:Valine = 1:2:1) or taste-, volume-, and color-matched placebo (PL). 
Participants were blinded to treatment to prevent any potential placebo effects on scores of 
subjective scales. Participants then performed six sets of ten repetitions of isokinetic 
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eccentric right knee extensions and flexions at 1.05 rad/s (60°/s). One-minute rest intervals 
were given between sets. Participants were verbally encouraged to maintain a peak torque 
equal to or greater than 120% of peak concentric torque. Participants were also allowed to 
view the computer monitor to observe their torque during the eccentric exercise. Ratings of 
perceived exertion (RPE; 6) were measured after the first, third, and sixth sets. After 
eccentric exercise, subjective muscle soreness was assessed; heart rate and blood pressure 
were measured. A second small blood sample (5 ml) was taken. Heart rate and blood 
pressure were measured fifteen minutes post-exercise. Participants were requested to refrain 
from eating or drinking (except water) for two hours after leaving the lab to prevent 
confounding results from additional nutrients.  
Participants entered the lab 24 and 48 hours later after an overnight fast. Body mass, 
heart rate, and blood pressure were measured. Subjective muscle soreness of the right leg was 
assessed. A small blood sample (5 ml) was taken. A five-repetition isokinetic strength and 
power test was performed. Ratings of perceived exertion were measured. After the strength 
and power test, subjective muscle soreness was assessed; heart rate and blood pressure were 
measured. 
Plasma CPK enzyme activities were analyzed in duplicate after all samples were 
collected. Plasma LDH enzyme activities were analyzed in duplicate within 48 hours. Plasma 
lactate dehydrogenase and creatine phosphokinase enzyme activities were analyzed using 
Pointe Scientific, Inc. (Canton, MI) reagent sets, according to manufacturer’s instructions (9; 
14).  
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At least four weeks after the first trial, participants completed a second trial. The 
second trial was identical to the first with the exception of participants receiving the other 
treatment. 
Statistical Analyses 
Data were analyzed using SPSS 15.0 statistical analysis software. Sample size was 
determined based on power analysis using a power to observe differences set at 0.8. Missing 
data were replaced with the mean of the corresponding variable. This was accomplished by 
the series mean method for replacing missing values. Data were screened for normality of 
distribution and equality of variances. When appropriate, non-normal data were transformed 
into ranked cases from smallest to highest for all trials combined. Ranks were then separated 
by trial number for analysis. Data were analyzed using ANOVA with repeated measures on 
the second and third factor (gender x treatment x time). Partial η2 was used to determine 
effect size (ES). Post hoc or pairwise mean differences were examined after Bonferroni 
adjustments. Differences between men and women were tested at baseline by independent t-
tests. Change scores were analyzed by independent t-tests (trial). Effect sizes of change 
scores were calculated using pooled standard deviations to determine meaningfulness. Level 
of significance was set at P < 0.05. An a priori hypothesis was peak torque and average 
power during five-repetition strength tests would be highly correlated. Pearson r for peak 
torque and average power for day one, two and three was 0.965, 0.979 and 0.968, 
respectively. All correlations were significant (P < 0.01). Therefore, peak torque will be 
omitted from analysis and discussion. All data are presented as means ± standard errors.  
RESULTS   
Mean knee extension power 
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Men had greater mean knee extension power output than women (P < 0.001, partial 
η
2
 = 0.578, Figure 1). The main effects for treatment and time were not significant. The 
treatment × time interaction tended to be significant (P = 0.107, partial η2 = 0.026). Because 
a borderline quadratic effect was observed for the interaction of time and treatment (P = 
0.085, partial η2 = 0.034), change scores were analyzed separately for men and women. Sub-
group analysis of change in mean power output from day one to day two showed that, for 
women, mean knee extension power output was reduced one day after eccentric exercise in 
the PL trial but not in the BCAA trial. (P = 0.02, ES = 0.67). For men, treatment did not 
affect change in mean knee extension power output from day one to day two.  
Mean knee flexion power 
Men had greater mean knee flexion power output than women (P < 0.001, partial η2 = 
0.319, Figure 2). The main effect for time was significant (P < 0.001 partial η2 = 0.255); 
mean flexion power output was greater on day one than day two and three (P < 0.05). The 
main effect for treatment was not significant. The gender × time interaction was significant 
(P < 0.001, partial η2 = 0.172); in men, mean knee flexion power output was greater on day 
one than day three (P < 0.05). Because a borderline quadratic effect was observed in mean 
knee flexion power output for the interaction of gender and time, (Quadratic P = 0.16), 
change scores were analyzed separately for men and women. Sub-group analysis of change 
in mean power output from day one to day two showed that, for women, mean knee flexion 
power output was reduced one day after eccentric exercise in the PL trial but not in the 
BCAA trial. (P = 0.03, ES = 0.65). For men, treatment did not affect change in mean knee 
flexion power output from day one to day two.  
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Creatine phosphokinase activity 
Data screening found that creatine phosphokinase enzyme activity was not normally 
distributed (Kolmogorov-Smirnov, P < 0.01). Because assumptions of sphericity were not 
met (Huynh-Feldt = 0.521), multivariate tests for interactions were used. The main effect for 
gender in regard to creatine phosphokinase activity was significant (P < 0.001, partial η2 = 
0.372, Figure 3). Men had higher creatine phosphokinase levels than women. The main effect 
for time was significant (P < 0.001, partial η2 = 0.612); CPK levels were higher day two and 
day three than before or after eccentric exercise on day one. The main effect for treatment 
was not significant.  
Lactate dehydrogenase activity 
Data screening found that lactate dehydrogenase enzyme activity was not normally 
distributed (Kolmogorov-Smirnov, P < 0.01). Because assumptions of sphericity were met 
(Huynh-Feldt = 0.993), univariate within-subjects tests were used. The main effect for gender 
in regard to lactate dehydrogenase activity was significant (P < 0.001, partial η2 = 0.164, 
Figure 4); men had higher levels of lactate dehydrogenase than women. The main effects for 
treatment and time were not significant.  
Leg muscle soreness 
Data screening found that leg soreness was not normally distributed (Kolmogorov-
Smirnov, P < 0.01). Because assumptions of sphericity were not met (Huynh-Feldt = 0.644), 
multivariate tests for interactions were used. The main effect for time in regard to soreness 
was significant (P < 0.001, partial η2 = 0.793, Figure 5). Leg muscle soreness was reported to 
be greater on day one after eccentric exercise and day two before and after isokinetic testing 
than before eccentric exercise on day one (P < 0.05). Leg muscle soreness was reported to be 
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greater on day three both before and after exercise than day two and day one (P < 0.05). The 
main effects for gender and treatment were not significant.  
Ratings of perceived exertion 
 Data screening found that RPE were not normally distributed (Kolmogorov-Smirnov, 
P < 0.01). Therefore, data were transformed into ranked cases from smallest to highest for all 
trials combined. Ranks were then separated by trial number for analysis. Because 
assumptions of sphericity were not met (Huynh-Feldt = 0.739), multivariate tests for 
interactions were used. The main effect for time in regard to ratings of perceived exertion 
was significant (P < 0.001, partial η2 = 0.649). Ratings of perceived exertion were lower after 
the first set of eccentric exercise than after the third set, which in turn were lower than the 
RPE after the sixth set. The main effects for gender and treatment were not significant.  
Side effects 
Anecdotally, none of the participants reported any negative side effects from BCAA 
supplementation. 
DISCUSSION 
The purpose of this study was to determine the effects of acute ingestion of BCAA on 
muscle function, plasma markers of muscle damage, and subjective evaluation of muscle 
soreness after eccentric knee extensions and flexions. To our knowledge, this is the first 
study to examine the effects of acute BCAA ingestion on these measures.  
The most important finding of the current study was that ingestion of 8 g BCAA 
helped maintain mean power output 24 hours after eccentric exercise in middle-aged women. 
Mean power output did not decrease from day one to day two for either knee extensions or 
flexions in the BCAA trial, while mean knee extension and flexion power output decreased 
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from day one to day two in the PL trial. The calculated effect sizes were of moderate 
magnitude. Sugita et al. (33), examined the effects of taking an amino acid mixture (5.6 g, 
30% BCAA by weight) b.i.d on muscle performance after eccentric exercise. Peak isometric 
muscle torque was greater after intake of amino acids two, three, and six days after eccentric 
exercise. These findings suggest that BCAA supplementation may attenuate losses of muscle 
performance after eccentric exercise. 
Interestingly, acute ingestion of 8 g BCAA did not maintain mean power output in 
men. Our results corroborate the findings of others that have shown men and women may 
respond differently to eccentric exercise. Sewright et al. (28), reported that women 
experienced greater immediate relative strength loss than men after 50 maximal eccentric 
contractions of the elbow flexors of the non-dominant arm. Furthermore, a disproportionately 
greater number of females than males demonstrated force reductions of > 70% maximal 
voluntary contraction (MVC) after eccentric contractions. Men, however, had greater CPK 
responses four days after eccentric exercise than women. In our study, men had higher CPK 
and LDH levels than women. In contrast to Sewright and colleagues, we observed loss of 
muscle torque, power, and total work performed in the knee flexors of men, not women. The 
reason for the gender differences in response to eccentric exercise is unknown. Hormonal 
differences between men and women, particularly estradiol, may influence the response to 
eccentric exercise. Amelink and Bär (1) suggested that estrogen may serve to protect the 
female muscle membranes in rats. Another proposed explanation of gender differences in 
force or power generation after eccentric exercise is possible differences between men and 
women in habitual muscle use. Untrained muscles are more prone to damage than trained 
muscles (7). The lower level of physical activity in females (35) may explain their greater 
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levels of muscle damage or loss of muscle function after eccentric or novel exercise. 
However, in our study, men had less mean power, torque, and total work performed for knee 
flexions 48 hours after eccentric exercise than before eccentric exercise. This trend was not 
observed in women. While gender differences in response to eccentric exercise may exist, to 
our knowledge, the mechanisms have yet to be elucidated. Furthermore, contradicting 
findings exist regarding such gender differences.  
  It is plausible that men and women respond differently to BCAA intake. Men oxidize 
leucine at a higher rate than women and also have lower nonoxidative leucine disposal than 
women during exercise, suggesting that women have higher rates of protein synthesis than 
men during exercise and may therefore experience greater benefit from BCAA 
supplementation (19). We observed that mean flexion and extension power output were 
maintained when women consumed BCAA. Others studies examining the effects of BCAA 
on strength and performance in males found that BCAA may not improve performance. 
Leucine supplementation for 19 days did not affect knee extensor strength in elite wrestlers 
(23). Leucine supplementation (100 mg/kg bodyweight) before and during a strength training 
session did not affect counter movement jump performance in competitive male power 
athletes (26).  In contrast,  leucine supplementation (45 mg/kg body weight) for six weeks 
increased relative peak power during a ten-second all-out arm crank test in competitive 
outrigger canoeists (9). Interpreting our results in light of these studies previous is difficult, 
since our participants were not highly trained athletes.   
Acute BCAA supplementation did not affect enzymatic markers of muscle membrane 
damage (CPK and LDH) in the current study. Others report that BCAA supplementation may 
attenuate exercise-induced muscle damage or muscle proteolysis (8, 20, 25, 34). BCAA (77 
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mg/kg) administered before 60 minutes of knee extensor exercise suppressed endogenous 
protein breakdown in men (20). In our study, endogenous protein degradation was not 
measured. Longer-term BCAA supplementation (12 g/d, 14 d) reduced CPK and LDH 
increases in blood for up to five days after 120 minutes of cycle ergometer exercise at 70% 
VO2 max in males (8). An amino acid (6.6 g/d, 30% BCAA, by weight) mixture administered 
for one month to middle- and long-distance collegiate track runners significantly reduced 
serum CPK levels pre-test to post-test during training (26). BCAA supplementation (12 g/d, 
15 d) prevented an increase in urinary urea nitrogen, hydroxyproline, and 3-methylhistidine 
20 hours after 600 m crawl stroke swimming competition (34). Furthermore, three weeks of 
BCAA supplementation before one week of high-intensity resistance training resulted in 
lower serum CPK and cortisol levels and higher serum total testosterone levels during and 
after training (29) Conversely, consumption of a carbohydrate/protein drink (23 g whey 
protein, 75 g carbohydrate, which contained 5.4 g BCAA) either before or after eccentric 
exercise did not affect muscle soreness, loss of muscle strength, or blood CPK levels up to 96 
hours after eccentric exercise (37). Jackman et al. (16) found that 7.3 g BCAA 
supplementation before and three times after eccentric exercise on the day of exercise and 
four times per day for two days after exercise did not affect plasma CPK or serum 
interleukin-6, an indirect marker of inflammation. Taken together, the results on the effects 
of BCAA supplementation on markers of muscle damage or membrane disruption are 
equivocal and may be influenced by length of supplementation period. 
Acute BCAA supplementation did not affect subjective evaluation of muscle soreness 
in the current study. This finding contradicts others (16, 31). Jackman et al. (16) observed 
that males receiving BCAA reported lower knee flexed soreness of the quadriceps 48 and 72 
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hours after eccentric exercise than those receiving placebo. However, BCAA 
supplementation did not influence overall soreness or knee extended soreness ratings. Acute 
BCAA supplementation (5 g) ingested 15 minutes before seven sets of ten repetitions of 
squat exercise decreased muscle soreness in women for four days after exercise and tended to 
be lower in males, compared to placebo (31). Shimomura et al. (31) suggested the gender 
difference in DOMS may be related to the smaller relative dose of BCAA consumed by 
males than females. Males ingested 77 mg/kg bodyweight BCAA, on average, whereas 
females ingested 92 mg/kg bodyweight BCAA. In our study, male participants consumed 
approximately 90.5 mg/kg bodyweight BCAA, whereas female participants consumed 
approximately 113.6 ml/kg bodyweight. Additional examination of the effects of relative 
BCAA dose on subjective appraisal of muscle soreness is warranted. Delayed-onset muscle 
soreness may theoretically influence exercise program adherence. According to the Hedonic 
Theory of Motivation and Affective Responses to Exercise, persons seek things that 
maximize pleasure and avoid those that cause displeasure. Furthermore, affective responses 
to a behavior may predict future behaviors (17). If an untrained person begins a new exercise 
regimen and experiences intense muscle soreness, it is possible that he or she ceases program 
adherence because of the displeasure experienced from the associated muscle soreness. 
Supplements possessing anti-soreness properties may therefore become central in the effort 
to promote health by increasing physical activity program adherence.  
The major limitation of the current study is that participants’ diets were not recorded 
and replicated. It is possible that potential prophylactic effects of acute BCAA 
supplementation on muscle soreness, muscle function, or membrane disruption were 
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prevented from dietary intake differences between trials. A follow-up study in which diet is 
recorded and replicated is highly warranted.       
PRACTICAL APPLICATIONS 
Significant loss of muscle strength and power may occur during periods of muscle 
soreness. We observed that acute BCAA supplementation may attenuate loss of muscle 
function and may maintain muscle performance after eccentric exercise in middle-aged 
women. This finding may be important for strength and conditioning professionals working 
with middle-aged women involved in sports. In men, mean power, peak torque, and total 
work performed during knee flexions were lower 48 hours after eccentric exercise, regardless 
of treatment. We did not observe these losses of muscle function in women.  
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Figure Legends 
Table 1. Participant characteristics. All values are means ± SE. 
Figure 1. Mean (± SE) extension power. BCAA indicates branched-chain amino acids; PL, 
placebo.  Men significantly different than women (main effect; P < 0.001). 
 
Figure 2. Mean (± SE) flexion power. BCAA indicates branched-chain amino acids; PL, 
placebo. * Men significantly different than women (P < 0.001). † Significantly different than 
day 1 (P < 0.05).  
 
Figure 3. Mean (± SE) plasma creatine phosphokinase levels. BCAA indicates branched-
chain amino acids; PL, placebo. * Men significantly different than women (main effect; P < 
0.001). † Significantly different than day 1 pre and post (P < 0.05). 
 
Figure 4. Mean (± SE) plasma lactate dehydrogenase levels. BCAA indicates branched-chain 
amino acids; PL, placebo. * Men significantly different than women (main effect; P < 0.001). 
  
Figure 5. Mean (± SE) leg soreness score. BCAA indicates branched-chain amino acids; PL, 
placebo. a, b, c Time points with different superscripts are different (P < 0.05). 
 
Table 1. Participant characteristics. All values are means ± SE. 
  Men (n = 20)   Women (n = 25)                
Age (yr) 47.1 ± 1.4   48.6  ± 1.2 
Height (cm) 177.8 ± 1.7*   162.1  ± 1.2 
Mass (kg) 88.4 ± 2.9*   70.4  ± 2.8 
BMI (kg/m2) 27.9 ± 0.9   26.8  ±  1.0 
FFM (kg) 68.3 ± 1.9*   46.7  ±  1.4  
Age, height, mass, body mass index (BMI), and fat-free mass (FFM). *Significantly different 
from women (P < 0.001). 
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Figure 1. Mean (± SE) mean extension power. * Men significantly different than women 
(main effect; P < 0.001). 
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Figure 2. Mean (± SE) mean flexion power.  * Men significantly different than women (P < 
0.001). † Significantly different than day 1 (P < 0.05)  
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Figure 3. Mean (± SE) plasma creatine phosphokinase levels. * Men significantly different 
than women (main effect; P < 0.001). † Significantly different than day 1 pre and post (P < 
0.05). 
 
 
 
 
129 
 
0
10
20
30
40
50
60
70
80
90
100
110
0
10
20
30
40
50
60
70
80
90
100
110
L
ac
ta
te
 d
eh
yd
ro
g
en
as
e 
(U
/L
)
Placebo
BCAA
Placebo
BCAA
Pre Post Day 2 Day 3
Day 1
Women
Men*
L
ac
ta
te
 d
eh
yd
ro
g
en
as
e 
(U
/L
)
L
ac
ta
te
 d
eh
yd
ro
g
en
as
e 
(U
/L
)
L
ac
ta
te
 d
eh
yd
ro
g
en
as
e 
(U
/L
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Mean (± SE) plasma lactate dehydrogenase levels. * Men significantly different 
than women (main effect; P < 0.001).  
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Figure 5. Mean (± SE) leg soreness score.  a, b, c Time points with different letters are different 
(P < 0.05). 
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